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In support of the implementation of the European Commission recommended definition of a 
nanomaterial the Institute for Health and Consumer Protection of the Joint Research Centre of the 
European Commission has been developing potential methods for measuring nanoparticle number 
size distributions. 
As part of this activity a method which combines a particle size separation (Asymmetric Flow Field 
Flow Fractionation (AF4)) step and a particle detection/quantification step (Induction Coupled 
Plasma-Mass Spectrometry (ICP-MS)) has been examined and optimised for the analysis of aqueous 
dispersed silver nanoparticles. Following an internal validation, the method has been documented in 
the form of a Standard Operating Procedure (SOP) designed to provide all the necessary information 
to allow the method to be applied by suitably equipped external laboratories. To verify the 
transferability of the method an international ring-trial was organized by JRC in which 8 independent 
laboratories were provided with detailed documentation and suitable test materials to allow them 
to test the transferability of the SOP.  
This report details the organization of the trial, presents the experimental results obtained and 
summarises the conclusions and recommendation coming from a detailed consideration of the data 
obtained. 
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Executive Summary  
Implementation of the European Commission recommended definition of a nanomaterial within the 
context of legislative controls requires that enforcement laboratories be provided with fit-for-
purpose analytical methods. Currently no suitable validated analytical methods are available for this 
purpose.  
To address the analytical challenges and to provide valid technical input to potential legislators JRC-
IHCP has, on specific request from DG-SANCO, begun a study program aimed at the development of 
methods which can be applied to measuring the number size distribution as required for the 
technical implementation of the common definition for the term nanomaterial. 
As part of this activity a detailed study was undertaken by JRC to develop specific methods for the 
analysis of aqueous dispersed nanoparticles. After careful evaluation of a range of possible analysis 
techniques, development work was started on a method which combines particle size separation by 
Asymmetric Flow Field Flow Fractionation (AF4) step with a particle detection/quantification step 
based on Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). The simplified method requires 
the use of pseudo-standards to calibrate particles size and concentration. These two methods 
together allow the measurement of a particle mass-size distribution which may, assuming the 
particles are near spherical, be mathematically converted into a number-size distribution as required 
by the EU definition. 
This general method is being studied for use with a number of high priority nano-materials and in 
particular has undergone detailed development for use with one specific type of silver nanoparticle 
dispersion.  At this time the method for detection and quantification has now been developed by JRC 
into a simplified Standard Operating Procedure (SOP) which has been used in the first stage of a 
small scale inter-laboratory comparison. 
The scope of this study was to evaluate whether the basic particle separation methodology could be 
transferred from the development laboratory (JRC) to the other participant laboratories in the trial. 
To assist in the method transfer a series of pseudo-standards composed of solution of near mono-
dispersed silver nanoparticles with known size and concentration were supplied to the participant 
laboratories.  These materials, when used singly or prepared as appropriate mixtures, were to be 
used to optimize and verify the efficiency of the separation methodology when applied in each 
participant laboratory. 
As a verification of the optimized separation the participants were also supplied with two unknown 
samples (A and B) which were to be analysed with no prior knowledge of their composition.  These 
samples were made by combining appropriated quantities of the 50nm and 100nm dispersions so as 
to produce a mixture in which the number of 50nm and 100nm particles was theoretically equal. 
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This particular mixture was chosen as this represent the borderline case between a nanomaterial 
and a non-nanomaterial under the criteria of the EU recommended definition.  The following report 
will detail the results and present conclusions on the outcome of the study. The results obtained 
have led to the following main conclusions 
1) The separation methodology, when applied with the reference standards was found to be 
transferable to different laboratories with all laboratories being able to separate the recommended 
mixtures of mono-dispersed materials.   
2) In the course of the study it was found that two laboratories reported problems of 
separation resulting from the quality of the separation membranes. Substitution of membrane with 
that from alternate batches or alternate manufacturers was found to resolve the problem. It should 
be noted that during method development this problem has also been observed by the organizing 
laboratory (JRC) although during the laboratory trial the problem was not observed.  
3) The separation methodology, when applied with the “unknown samples A and B” and using 
UV absorption detection showed five of nine laboratories as being able to clearly separate the 
bimodal mixture. Three of the nine laboratories were able to obtain elution curves which showed 
evidence of the two peaks but with poor signal/noise ratio. Only one laboratory was not able to 
show evidence of the bimodal mix. 
4) A statistical analyses of the result obtained from the unknown samples showed that 
acceptable accuracy and reproducibility was obtained for the measurement of nanoparticle size but 
that the quantification of the amount of silver using the ICP-MS was not sufficiently accurate or 
reproducible.  
5) Sample stability: It is known that silver nanoparticles often exhibit problems of stability and 
may suffer from aggregation or dissolution during long term storage. A number of the participants 
were not able to complete their analyses in the recommended time period and it is likely that this 
may have influenced negatively on the quality of results obtained. 
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Glossary  
AgNP  Silver nanoparticles  
AgNP10, AgNP20…  Silver nanoparticles of nominal diameter of 10 nm, 20 nm…   
AF4 Asymmetric-Flow-Field-Flow-Fractionation 
Agglomerate  Collection of weakly bound particles or aggregates or mixtures of the two 
 where the resulting external surface area is similar to the sum of the surface 
 areas of the individual components. 
Aggregates  Particle comprising strongly bonded or fused particles  
CLS Centrifugal Liquid Sedimentation 
CPS Counts Per Second (ICP-MS signal output)  
DLS  Dynamic Light Scattering 
EM Electron Microscopy 
FFF Flow Field Fractionation 
ICP-MS Inductively Coupled Plasma Mass Spectrometry 
ICP-OES Inductively Coupled Optical Emission Spectroscopy 
MALS Multi-angle light scattering  
Particle A minute piece of matter with defined physical boundaries; 
SEM Scanning Electron Microscopy  
TEM  Transmission Electron Microscopy 
ILC Inter-laboratory comparison 
CAT Chemical Assessment and Testing unit 
NBS NanoBioSciences Unit  
SOP Standard Operation Procedure 
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1 Introduction 
In 2011 the European Commission, in response to a request from the European parliament, agreed 
on a common definition for the term nanomaterial which requires that materials be characterized in 
terms of the number size distribution of their constituent particles[1][2]. Implementation of this 
definition within the context of legislative controls requires that enforcement laboratories be 
provided with fit-for purpose analytical methods.  
To address the analytical challenges and to provide valid technical input to potential legislators JRC-
IHCP has, on specific request from DG-SANCO, began a study program aimed at the development of 
methods which can be applied to the technical implementation of the above noted definition. The 
outcome of this study would, ideally, result in the publication of a validated test protocol applicable 
to at least one technically relevant type of liquid dispersed nanoparticle. 
As part of this activity a detailed study was undertaken by JRC to develop a specific method for the 
analysis of aqueous dispersed silver nanoparticles by use of combined Asymmetric Field Flow 
Fractionation (AF4) and Induction Coupled Plasma-Mass Spectrometry (ICP-MS). This method has 
now been developed into a simplified Standard Operating Procedure(SOP) which is reported in 
Annex 5 of this document.  The further development of this procedure towards becoming a 
validated test protocol now requires the method be evaluated by inter-laboratory ring-trials. 
Given the technical complexity of the problem, it was decided that the process of validating the SOP 
through inter-laboratory studies should be split in two stages: a method familiarization stage (Stage 
1) and an eventual validation study (Stage 2). This document will detail the results obtained by the 
participants in stage 1 of this process. 
The first stage of this study was to assess whether the analysis procedures developed by JRC can be 
successfully transferred to other independent laboratories equipped with comparable but not 
necessarily identical AF4-ICP-MS facilities.  It was foreseen that the methodology be usable by 
laboratories with existing experience of AF4 but not necessarily with experience of  the nanoparticle 
mixtures of the type being examined here. It was, therefore, necessary that each laboratory optimize 
the instrumental conditions for their own combination of equipment using a series of mono-modal 
(near mono-dispersed) samples of declared size and concentration supplied by JRC. For an 
evaluation of the final optimized conditions simple bi/tri-modal samples of undeclared size and 
concentration were supplied for analysis.  
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2 Materials and methods developed for the inter-laboratory comparison  
As a first step in addressing the analytical challenges of the definition an experimental study was 
initiated within JRC-IHCP whose scope was to identify flexible methods for the analysis of 
nanoparticle size distributions. In identifying suitable methods consideration was given not only to 
technical issues but the urgency to find possible methods and procedures which would be as cost 
effective as possible. The following section details the considerations given in the choice of the 
method and analyte particle together with a description of the chosen method itself. 
2.1 Choice of analytical method for study 
Currently there is no single analytical method able to satisfy the requirement of the definition but a 
variety of methods exists which could be applied in the resolving parts of problem. A detailed 
overview of the area and has been prepared by JRC and published in series of reference reports [3] 
[4], [5]. In particular, this first of these reviews [3] provides a comprehensive overview of common 
methods with descriptions of their operational principles and their advantages and disadvantages in 
regard to the making measurements of nanoparticle number size distributions.  
After a detailed consideration of the possible methods available the combination which was thought 
most likely to be able to satisfy, at least in part, the requirement of the definition for the largest 
possible range of materials and concentrations was Asymmetric Flow Field Fractionation (AF4) 
separation combined with on-line elemental detection by Inductively Coupled Plasma-Mass 
Spectrometry (ICP-MS). This combination permits the fractionation of poly-dispersed mixtures as a 
function of their size and then quantifies the mass of particulates in those fractions by use the high 
sensitivity element specific ICP-MS.  Provided that a suitable method is available to determine the 
mean particle size in the eluted fractions a mass-size distribution may be generated and then, 
assuming the particles are near spherical, be mathematically converted into a number-size 
distribution as required by the EU definition. The resulting mass-size distribution technique of 
designed to allow calculations of number size distribution from an experimentally determined mass 
size distribution as follows. The following section will describe the following. 
2.1.1 Field flow fractionation (FFF)  
Field-Flow Fractionation[6] is actually a family of separation techniques, comprising various different 
sub-techniques which all utilize the same basic separation principle but employ different force fields. 
Depending on the type of separation field used the technique may be called Flow Field-Flow 
Fractionation, Sedimentation Field-Flow Fractionation, Thermal Field-Flow Fractionation or Split 
Flow Thin Cell Fractionation (SPLITT). The separation process is similar to chromatography except 
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that no solid phase is used and the separation is based on applying a physical force to the particles in 
solution as opposed to a chemical interaction as shown in Figure 1.  
Most variants of FFF perform their separation in a thin ribbon like channel of liquid which flows 
between two flat plates separated by a thin spacer foil of typically 100-500 µm thickness. In such a 
narrow channel the liquid moves under laminar flow conditions which means that the velocity of the 
liquid varies with the distance from the channel wall, slowest at the wall and fastest in the centre of 
the channel. When a perpendicular separating force is applied to the channel the particles will move   
toward the lower wall while the natural Brownian motion in solution will tend to counteract this 
effect allowing particles to diffuse back toward the centre of the channel. When these two forces 
reach an equilibrium the particles become distributed across the channel with the smaller, faster 
diffusing particles tending to pass more time on the high flow region while the larger slower 
diffusing particle remain more in the slower flow stream near the wall.  
 
Figure 1  General principle of FFF operation
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Image: Postnova Analytics GmbH:  http://www.postnova.com/general-theory.html) 
 
The overall effect is that as the particles flow along the channel, smaller particle will move faster and 
be eluted from the column before larger slower moving particles. In the majority of FFF methods the 
particle separation is based principally on their hydrodynamic size or, in the case of Sedimentation 
Field-Flow Fractionation, a combination of hydrodynamic size and particle density. 
In this work the most flexible and commonly used version of FFF, Asymmetric Flow Field Flow 
Fractionation (AF4), has been chosen for method development. The AF4 method utilises a very 
specific channel geometry which is shown in schematically in Figure 2. 
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Figure 2  Schematic of Asymmetric Flow Field Flow Fractionation(AF4) channel 
Image: Wyatt Technology: http://www.wyatt.com/library/theory/flow-field-flow-fractionation-theory.html 
 
As can be seen the AF4 channel is formed by a thin spacer foil which separates an impermeable 
upper wall from a lower semipermeable membrane supported by a porous frit. During the particle 
separation phase of operation a flow of eluent is pumped through the AF4 channel generating a 
laminar flow velocity profile while a second pump simultaneously extracts a portion of the liquid 
across the membrane and frit.  The resulting tangential flow of liquid, known as the cross flow, 
provides the separating force which pushes the particles towards the semi-permeable membrane.  
The membrane used in AF4 may have various molecular cut-of values, ranging from as low as 
300Dalton to more than 100kDalton depending on the sample type which has to be fractionated.  
The membrane used needs to have a pore size which is sufficiently small as to retain the particles 
within the channel while still allowing the flow of liquid without excessive pressure drop. For the 
separation of typical nano-particulate materials membranes with a 10kD cut-off provide a good 
compromise for effective retention of particulates with a moderate pressure drop.  The AF4 method 
can be applied to the fractionation of particles in the range from around 1nm to over 500nm and 
therefore is broadly suitable for application to the EC definition.  
2.2 Choice of detection and size/mass quantification method    
It is important to note that FFF is, in reality, a separation technique, not a size measurement 
technique and the FFF column must normally be coupled to a detector system that performs on-
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line/off-line detection, quantification and/or sizing. In some cases quantification of the 
mass/concentration of particles may be achieved using moderately priced on-line detectors such as 
UV-Visible light absorption or refractive index with the actual applicability of the method being 
dependant of the type of particles. In other cases, the levels of sensitivity necessary may require 
more costly and sophisticated element specific methods such Inductively Coupled Plasma Mass 
Spectrometry (ICP-MS) which is a highly sensitive analytical technique which uses mass spectrometry 
for the detection of  metals and several non-metals in liquid samples at concentrations as low as one 
part in 1012 (part per trillion) for batch analysis. For the measurement of size, static (MALS) and 
dynamic light scattering (DLS) methods may be applied on-line although such techniques again add 
significant cost and may not be able to give the desired information due to key technical limitations. 
For example, MALS may be sufficiently sensitive to detect the presence of small particles but the 
physical basis of the measurement impose limits on the lower size of particles which can be sized. In 
the case of DLS the lower size does not have the same intrinsic limitation but instead may be unable 
to operate because of the low scattered light signal which is achievable with small particles at the 
concentration levels typical of analytical FFF.  
In the situation where issues of sensitivity or cost make the use of direct on-line sizing undesirable 
there remain a number of other alternatives which can be considered. One of the simplest strategies 
for sizing and quantifying the materials eluted from an FFF system is to do time resolved collection of 
sample aliquots and then do off-line analysis of each sample to determine the size and 
concentration. This strategy offers the advantage of being able to analyse the samples under 
optimised conditions while also allowing the analysis instrumentation to remain independent of the 
FFF systems. This would be relevant in laboratories where high cost polyvalent analytical instrument 
such as ICP-MS are available but cannot be dedicated exclusively to use with FFF.  The disadvantage 
of the off-line analysis method is that, depending in the sampling time, the time/size resolution may 
be reduced and in most cases will greatly increase the time necessary to generate a full data set of a 
particle size distribution.  In this strategy particle size could be determined off-line using a variety of 
methods including DLS, MALS and electron-microscopy.  
In the absence of any other instrumental methods the particle size can be calculated from the 
experimentally measured values of retention time following application of the established, basic 
theory of FFF. It should  be noted that this theory generally assumes "ideal" separation conditions 
and therefore no  significant interaction between particles and membrane and this is cannot always 
guaranteed particularly when examining particle with unknown or poorly defined surface chemistry. 
In a variation of this strategy retention time can be used to determine particles size by use of 
experimentally determined calibration curves of size and retention time obtained using (certified) 
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particle size standards. Ideally this should be done using particles which are chemically similar to 
those expected in the unknown samples as variations in surface chemistry may modify retention 
times as a result of different particle-membrane interactions.  If chemically identical calibration 
standards are not available then alternatives such as size certified latex particles may be considered 
provided that eluent and elution conditions can be determined which minimise particle-membrane 
interactions.  
2.2.1 Combined AF4-ICP-MS 
After careful evaluation of a range of analyse methods, development work was started on a method 
which combined a particle size separation step (Asymmetric Flow Field Flow Fractionation (AF4) and 
a particle detection/quantification step (Induction Coupled Plasma-Mass Spectrometry (ICP-MS)). 
For reasons of cost, complexity and expected availability in control laboratories it was decided not 
include on-line size measurements as part of the proposed method but rather to initially rely on a 
calibration of size and retention time. When combined together the two methods can be used to 
derive a particle number-size distribution by the following four steps.  
 Firstly, the relationship between retention time and particle size would be determined for 
AF4 system using a range of mono-dispersed standards.  
 Unknown samples would then be fractionated using the AF4 with simultaneous on-line 
determination of particulate mass concentration by ICP-MS  
 The resulting fractograms of mass concentration and retention time would be converted 
into a mass-size fractogram by applying the calibration curve previously determined using 
size standards. 
 Particle number size distribution would then be calculated from the experimentally 
determined mass-size distributions assuming that the particles have a known uniform 
chemical composition and that they have a known size/shape. 
It is the view of the authors that the proposed combined method, AF4-ICP-MS, cannot satisfy all the 
needs of the definition but given the urgent need of the legislative bodies to have workable 
solutions to the analytical challenges posed by the nanomaterial definition it may, with suitable 
development, offer an interim solution. It is certainly true that electron-microscopy may give a more 
complete and reliable assessment of a materials nano-status this solution requires equipment and 
highly skilled operators which may be prohibitively expensive for routine use. While it is valid to say 
that the proposed AF4-ICP-MS method is not inexpensive if the whole system needs to be 
purchased, this effect is greatly reduced when it is considered that the most expensive component- 
the ICP-MS and its related infrastructure and technical support- is commonly available in the type of 
control laboratories who would be the principle user the type of protocol being examined in this 
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study.  In this case the cost of upgrading the ICP-MS with a basic AF4 system is achievable at less 
than 15% the purchase cost of STEM and less than 10% of a TEM. This combined with the low 
running cost and ease of operation make it an interesting option to resolving this complex analytical 
problem. 
2.3 Choice of particles and dispersion matrix for method development 
The choice of nanoparticle/dispersant combination in this work was the fruit of a consideration of a 
number of relevant technical points as well as priorities from the most immediate needs of 
legislators. The main technical points were the following. 
 The particles should be relevant to the current of future needs of the legislators 
 The particle types  must be specifically detectable by a ICP-MS 
 It should be possible to obtain or fabricate suitable sample solutions for use in method 
development and in later validation studies. 
 If possible, the detection (not quantification) should be possible with alternative methods 
such as UV or fluorescence spectroscopy to reduce the dependency on the more complex 
ICP-MS during method development. 
From discussions with DG-SANCO, DG-ENT, DG-ENV a priority list of materials was produce as shown 
in Table 2-1 
Table 2-1 Priority materials with possible nanomaterial content 
Material Priority Specific applications 
Ag 1 Food contact materials  and  additives 
Titanium dioxide 1 Food contact materials and additives 
Basic methacrylate copolymer 1 Nutritional supplements 
Nanoclays 2 Food contact materials 
Silicon dioxide 2  
Magnesium oxide 2  
Titanium nitride 2  
Carbon black  2  
Metal oxides 2  
 
From this list of nano-materials consideration was given to the higher priority materials to assess 
which had the greatest possibility of being developed into a working method in the minimum 
possible time. The basic methacrylate polymer was excluded as there is currently no sensitive 
method of specifically detecting and quantifying organic based nanoparticles. The nano-clay 
materials were excluded as these have variable non-standard compositions and contain many 
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elements which are ubiquitous in many possible test matrixes. The remaining two materials TiO2 and 
Ag both offer advantage and disadvantages in terms of detectability and availability. After due 
consideration the choice of Ag was made for a number of technical reasons. 
Firstly, Ag nano-particles are available commercially in highly monodisperse form and therefore 
adapted to the preparation of mixtures with particle number distributions which can be controlled 
and used for calibration. Secondly, Ag nanoparticles are, for a relatively wide range of sizes, plasmon 
resonant materials which mean that they exhibit material specific absorption in the UV-Visible 
range. This absorption is, for much of the particle size range, very intense and so permits the use of 
low-cost high sensitivity UV-Visible HPLC type detector for use in the method development. 
Unfortunately the intensity and peak wavelength of this absorption varies with the size (and shape) 
of the Ag particles and consequently this detector cannot reliably be directly used for routine 
quantification. However for the purposes of the method development required in this study the high 
sensitivity of the UV-Visible HPLC detector proved to be a very valuable tool and for much of the 
work this low cost method of detection was able to substitute than the much more complex and 
costly ICP-MS. 
Finally, in step 2 of the general method it was intended to couple the output from the AF4 system to 
the ICP-MS for the real-time quantification of the particle mass in the eluted solution. In this case it 
is necessary that the particles can be efficiently and rapidly ionized in the plasma torch before 
sampling with the mass spectrometer.  This can be achieved much more easily and reliably with 
relatively volatile metals particle such as silver as compared to highly stable refractory oxide such as 
TiO2 thus reducing/eliminating the need for pre-digestion before introduction to an ICP-MS system. 
A further consideration was that digestion of TiO2 generally requires the use of hydrofluoric acid 
which is not compatible with on-line work and represents a very serious safety hazard which should 
only be used in specially equipped laboratories with appropriately trained personnel. 
Having decided that the nanoparticle most appropriate to this preliminary study would be Ag 
consideration was given to the type of liquid matrix in which to disperse the nanoparticles. As 
previously mentioned, at the time of writing this document there are no validated method nor 
reference standards for calibrations according to the EU recommended definitions. Consequently, 
for this study it was decided to utilise a very simple nanoparticle mixture which would eliminate the 
complications of pre-analysis sample preparation steps so allowing the laboratories to concentrate 
on the instrumental aspects of the process.  
For reasons of technical simplicity and commercial availability it was decided that the study would 
utilise silver nanoparticles stabilised by sodium citrate-this being one of the most common form of 
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colloidal silver available commercially and therefore both relevant to future legislation and relatively 
easily sourced commercially.   
2.4 Method developed for the separation of the particles 
In summary, in this activity a method which combines a particle size separation (Asymmetric Flow 
Field Flow Fractionation (AF4)) step and a particle detection/quantification step (Induction Coupled 
Plasma-Mass Spectrometry (ICP-MS)) was developed and optimised for the analysis of aqueous 
dispersed silver nanoparticles. The method was developed specifically using sodium citrate stabilised 
silver nanoparticles which is one of the most common forms of this type of nanomaterial.  Following 
an internal validation, the method has been documented in the form of a Standard Operating 
Procedure (SOP) designed to provide all the necessary information to allow it be applied by suitably 
equipped external laboratories. The specific details of the method can be found in the SOP which has 
been included as Annex 5 of this report. 
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3 Description of Study 
The main objective of this phase of the ring-trial was to evaluate whether the basic particle 
separation methodology could be transferred from the development laboratory (JRC) to the other 
participant laboratories in the trial. One of the technical difficulties was that the different participant 
laboratories were equipped with a variety of different instruments (AF4 and ICP-MS) which meant 
that it was not possible to provide a single SOP with detailed instrument specific parameters. 
Instead, it was necessary to provide the participants with a generic procedure to optimize their own 
instrumental system starting from a basic set of recommended separation conditions. These 
conditions could then be modified until a predetermined minimum level of particle separation was 
verified based on numerical criteria specified in the SOP. Once the participants had verified that this 
phase had been completed successfully they could then apply this methodology to the analysis of 
two samples (A and B) whose composition (nanoparticle size and concentration) was not known to 
the participants.  
3.1 Samples for calibration and method development 
Nanoparticle dispersions containing near mono-dispersed silver nanoparticles were provided 
together with detailed information about the concentration and sizes of each. The nano-particle 
dispersions which were supplied had sizes in the range 10 to 100nm in size steps of approximately 
10nm. Full details of the materials supplied will be given later in Section 5.  
3.2 Standard Operating Procedure   
The SOP, which is reported in Annex 5, provided the ring trial participants with the following: 
i) A description of the nanoparticle standards  
ii) A step-by-step description of particles storage and handling conditions along with 
instruction on how to optimize the separation procedure. 
iii) A step-by-step description of the verification tests which had to be performed using 
predefined mixtures of two or more of the monodispersed nanoparticle solutions. From the data 
derived from these tests numerical values could be calculated to quantify the resolution and 
separation obtainable in each participant laboratory. Participants were requested to undertake 
method optimisation until predefined minimum values of resolution and separation could be 
achieved. 
iv) Detailed instructions of how to prepare and analyse the two blind test samples (A and B) 
using the optimised separation conditions developed and verified in steps (ii) and (iii) above. 
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3.3 Test samples (A and B) with undeclared composition 
The participants were supplied with two samples (A and B) which were declared to contain a mixture 
of two or more sizes of monodispersed nanoparticles whose identity (size and concentration) was 
not known to the participants.  The preparation of these samples is detailed later in section 8.1 but 
basically the solutions were made by mixing accurately known volumes (determined gravimetrically) 
of the 50nm and 100nm particle dispersions to give a theoretical number ratio of 1:1 of the two 
sizes. In this way the mixture was designed to simulate a particle mixture which would be a 
borderline case under the terms of the EU recommended definition. To ensure uniformity across the 
test both samples A and B were prepared as two individual batches which were then aliquoted to 
make the samples for distribution in the trial.  Sample A was provided at a high concentration of 
silver and was intended to be used by the participants after appropriate dilution in their 
laboratories. Sample B was provided at the correct working concentration and was designed to be 
used as supplied. In practice the two samples should have had exactly the same ratio of 50 and 
100nm particles since the sample B was prepared in JRC laboratories by diluting a portion of the 
sample A. The samples were prepared in this way to permit the following 
1) Evaluate the ability of the method to analyse samples close to the 50% number limit for the 
 definition 
2) Evaluate the repeatability/reproducibility by providing two samples which had the same 
 identical ratio of 50 and 100nm particles 
3) To provide data for use in determining appropriate sample concentrations for use in possible 
 future trials.  
It is well known that silver nanoparticle may be degraded by oxidation and exposure to light and that 
this effect is likely to be greater in highly dilute samples. By comparing the elution curves of sample 
B as supplied and sample A in a diluted state, information about the relative stability of the diluted 
sample be determined when exposed to full ring-trial conditions. It should be noted that prior to 
initiating the trial, stability tests on concentrated and diluted mixtures of nanoparticle silver were 
run by JRC and it was found that, under ideal storage condition there was minimal (<5%) loss of 
nanomaterial over the 4 week time period allowed for completion of the testing in the trial. This 
verification of sample stability could not take into consideration the addition deterioration which 
could occur during transport or non-ideal storage and handling conditions.   
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4 Description of Participants  
From the response to the call to participate in this ring trial a total of eight national, regional or 
university laboratories were identified as having suitable facilities to participate, partially or fully, in 
the first stage of this study. Amongst the eight external laboratories, only four were equipped with 
AF4 and on-line ICP-MS while the remaining laboratories were limited to using UV spectrometry as 
the only on-line detection method. In addition, one of these four laboratories (no.7) had access to 
off-line ICP-MS and was able to analyse time resolved fractions of the AF4 elution. 
Given the limited number of fully equipped laboratories in the trial, JRC also participated by 
analysing examples of the same batches of unknown samples A and B at a time point 3 weeks after 
the official start of the trail. This was done to increase the effective number of participants and to 
verify that the unknown samples could give representative results at a time point close to the 
maximum time allocated for completion of the study.     
For the purposes of this report the results will be presented in an anonymous way with the external 
measuring laboratories being referred to by a code number (2-9) while JRC will be indicated as 
participant (1). Each external laboratory will be informed of their own identifier number. 
4.1 Previous experience with AF4, ICP-MS and combined AF4-ICPMS   
In the original call to take part in the ring trial all potential participants were asked to provide an 
indication of their previous experience in the fields of AF4, ICP-MS and combined AF4-ICP-MS. The 
information supplied is shown below in the Table 4-1  
 
Table 4-1 Experience of participant laboratories  
Laboratory 
No. 
AF4 Experience ICP-MS 
Experience 
AF4-
ICPMS 
Participation 
(Full/Partial) 
1 Y Y Y Full 
2 Y Y Y Full 
3 Y Y Y Full 
4 Y Y Limited Full 
5 Y N/A N Partial 
6 Y N/A N Partial 
7 Y Y Off-line  Partial 
8 Limited Y Limited Partial 
9 Y Y Y Full 
 
As can be seen in Table 4-1 the majority of the laboratories have defined themselves as having an 
established experience in the use of AF4 while only 5, including JRC, have defined themselves as 
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having the necessary instrumentation as well as experience in the use of the full combination of AF4-
ICPMS. 
4.2 Equipment used by each participant 
Given the highly specialized nature of this study it was foreseen that it would be difficult to 
guarantee that all participating laboratories could have access to the same type of instrumentation 
as was used to develop the method at JRC. Consequently, the SOP was prepared in a relatively 
generic manner which provided the necessary guidance to develop, optimise and verify analysis 
procedures for the various instrument combinations. The list in Table 4-2 shows the equipment used 
in the various laboratories. 
 
Table 4-2 AF4 and ICPMS equipment available in each laboratory 
Laboratory No. AF4 ICP-MS 
1 Postnova AF2000 Agilent ,7700x 
2 Wyatt Eclipse 3+ Agilent ,7700x 
3 Wyatt, Eclipse 3 Agilent, 7500 ce 
4 Postnova AF2000 MF PerkinElmer, Elan DRCII, 
5 Postnova AF2000 MT N/A 
6 Postnova AF2000 MT N/A 
7 Postnova Analytics AF2000 Agilent 7500 ( Off-line) 
8 Wyatt, Dualtec Thermo X Series 2 
9 Wyatt, Eclipse 3+ Agilent, 7700x 
 
As can be seen in Table 4-2 only five laboratories, including JRC, had access to AF4 with on-line 
analysis by ICP-MS. It should be noted that participant No.7 also had access to ICP-MS off-line and 
has supplied information on the results obtained using this intermediate solution. These results 
could not be directly integrated into the statistical analysis of the online studies but instead will be 
presented separately in Annex 4 of this document. 
5 Description of materials used in test 
The nanoparticle dispersions used in the trial were sourced from two commercial suppliers. The first 
supplier (A) was specialized in the production of high precision(size) gold and silver nanoparticles 
and was able to produce a series of nine nanoparticle dispersions with nominal sizes of 
20,30,40…100 nm respectively.  Each material was provided with a detailed technical specification 
by the manufacturer in which size and concentration were quoted.  One additional material with a 
nominal size of 10 nm was purchased from a second supplier (B). This product was not accompanied 
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with a detailed technical specification but as this material was not for use in size calibration this was 
not a critical issue. Instead, this nanoparticle dispersion served only to verify that the AF4 elution 
method could adequately separate particles of 10nm from the void peak. Analysis of this material 
using CLS and Electron Microscopy (EM) showed that the size declared by the manufacturer was 
comparable with that effectively observed experimentally. To ensure that the data from the 
manufacturers A and B were reliable JRC undertook a more detailed series of independent analysis 
to verify the size, mono-dispersivity and concentration of the particles.  
5.1.1 Size and monodispersivity of silver nanoparticle solutions 
The particles used in the study were used as size calibrants with the size measurements being given 
by the values provided in the manufacturer certification. The sizes, along with other details, are 
reported in Table 5-1. 
 
Table 5-1 Size and concentration values for each type of Ag nanoparticle distributed in the study   
Standard Diameter TEM 
[nm]* 
First Standard 
Deviation[nm]* 
Hydrodynamic 
Diameter(DLS)[nm] * 
Concentration by 
ICP-MS[µg mL
-1
]** 
AgNP10 10(±4)*** N/A N/A 17.7 
AgNP20 19.6 1.6 N/A 19.1 
AgNP30 32.3 3.2 44.8 13.2 
AgNP40 40.6 3.0 53.7 18.3 
AgNP50 52.4 5.9 58.1 19.8 
AgNP60 57.4 4.0 66.7 19.4 
AgNP70 68.5 4.2 69.0 21.1 
AgNP80 77.1 6.4 83.0 20.0 
AgNP90 88.9 4.3 86.8 18.1 
AgNP100 99.4 7.0 97.7 18.7 
* Value from manufacturer specification certificate unless state otherwise 
** Value measured in JRC laboratories  
*** Nominal non-certified value by manufacturer 
5.1.2 Verification of mono-dispersivity by Centrifugal Liquid Sedimentation (CLS) 
To ensure that the particles used for method development were fit-for-purpose it was necessary to 
verify that the expected degree of mono-dispersivity was respected. To do this each type of particle 
was analysed by CLS to check the size distribution of each materials and to verify the presence of any 
eventual aggregation. The results of these analyses are shown below in Figure 3. The results confirm 
that the particle distribution are narrow mono-modal for all sizes except the those of 90nm and 
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100nm each of which shows a small secondary peak at higher size. This is consistent with the 
presence of a low concentration of dimers.     
 
Figure 3 CLS analysis of pseudo standard solution of Ag nanoparticles 
5.1.3 Verification of temporal stability under controlled conditions  
During this study samples were required to be stored at 4°C and once opened it was recommended 
that they be reclosed under an inert atmosphere of N2 or Ar. It was further requested that the 
samples be utilised within 4 weeks of delivery. These conditions were established following the 
results of a preliminary stability study in which nanoparticle mixtures were prepared and periodically 
analysed using CLS during a period of up to 4 weeks. Examples of these results are presented in 
Figure 4 where it can be seen that the particle mixtures show only minimal variation in quantity and 
size distribution during this time period.   
In addition to this, representative samples of the calibration solutions and the unknown samples A 
and B were stored at JRC and periodically analysed using CLS (samples A and B) and UV-Visible 
Spectrometry (calibration solutions). By undertaking these analysis during the 4 week period 
following dispatch of the test samples it was possible to confirm (see sections 6.1 and 6.2) the 
temporal stability of the materials. 
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Figure 4 CLS measurement of undiluted development mix from Time=0 to 4 weeks  
 
6 Results obtained during the Inter-Laboratory Comparison (ILC) 
The experimental results collated in this study cover three main aspects of ILC. 
 Verifying the stability of the test materials during the course of the ILC (JRC only) 
 Evaluation of effective separation (JRC and all participants) 
 Measurement of unknown samples A and B (JRC and all participants) 
Each of these three aspects will be considered in separate sections with the current section being 
dedicated to the verification of the stability of the test materials used in the study.  As has already 
been outlined in the Section 5.1.3 prior to initiating the organization of the ILC, JRC has confirmed 
the temporal stability of similar silver nanoparticle solutions and mixtures over time periods equal or 
greater than that consider necessary to complete the experimental phase of the ring-trial. However, 
given the relatively unstable nature of silver nanoparticles it was thought prudent to also repeat 
similar tests on the random examples of the materials distributed in the ILC. These tests were 
conducted periodically over the 4 week time period in which the participants were requested to 
complete their measurements.  In this way it was possible to evaluate the extent that nanoparticle 
instability could have on the quality of results and to ensure that samples would remain suitable for 
use through-out the duration of the trial.   
6.1 Verification of the stability of single pseudo-standards during test period 
Stock solutions of mono-dispersed silver nanoparticle-dispersions were monitored to verify their 
stability over a time period of 21 days from the time when the trial materials were dispatched to the 
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participant laboratories. This was done by determining the area of the absorbance-peaks of each 
stock solution (AgNP10nm, AgNP20nm, AgNP30nm, AgNP40nm AgNP50nm, AgNP60nm AgNP70nm, 
AgNP80nm AgNP90nm, and AgNP100nm). Figure 5.1 shows an example of how peak areas were 
integrated. Measurements were conducted once a week for three weeks. Fresh aliquots from the 
same vial were used each time. Spectra integration-windows for each stock solution/particle 
dimension are reported in Table 6-1 and Table 6-2. 
Except for AgNP10 and AgNP 90, the overall loss was below 1%. 
 
   
Figure 5 Example of integration window (here for AgNP30nm) 
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Table 6-1 Spectra window used for each stock solution 
Stock Solution Integrated Spectra Window 
[nm] 
AgNP 10 nm 321.5 – 500 
AgNP 20 nm 321.5 – 500 
AgNP 30 nm 325.5 – 500.1 
AgNP 40 nm 326.5 – 550.5 
AgNP 50 nm 324 – 600 
AgNP 60 nm 324 – 601.5 
AgNP 70 nm 323 – 657 
AgNP 80 nm 321.5 – 800 
AgNP 90 nm 321.5 – 800 
AgNP 100 nm 321.5 – 800 
 
Table 6-2 Integrated absorption peak areas for each monodispersed stock suspension 
Date 12 April 2013 19 April 2013 24 April 2013 3 May 2013  
Days elapsed 0 7 12 21  
Stock Solution Integrated absorption peak area Decrease of peak area 
on 21 days [%] 
AgNP 10 nm 134.147 133.105 132.302 130.087 3.0 
AgNP 20 nm 166.842 166.269 166.029 165.404 0.9 
AgNP 30 nm 121.064 120.72 120.774 120.493 0.5 
AgNP 40 nm 171.613 171.45 171.489 171.169 0.3 
AgNP 50 nm 181.015 181.039 181.307 180.838 0.1 
AgNP 60 nm 175.314 175.267 175.32 175.101 0.1 
AgNP 70 nm 198.068 197.662 197.53 197.2 0.4 
AgNP 80 nm 192.248 191.867 192.044 191.883 0.2 
AgNP 90 nm 165.407 157.57 157.614 157.715 4.7 
AgNP 100 nm 170.77 170.45 170.314 169.645 0.7 
The total decrease in absorption in the given integration windows was <5% for all stock solutions.  
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Figure 6 Overlaid absorption spectra for AgNP30nm during the testing period of the ring trial 
 
 
Figure 7 Spectra of all sizes of stock-solutions overlaid (3-May-2013) 
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6.2 Verification of the stability of unknown sample B during test period 
In addition to this a series of analysis were conducted on Sample B to verify whether the diluted test 
material was stable over the time scale of the study. To do this, samples were analysed by CLS 
periodically during the allocated time period. The figure below (Figure 8 ) shows CLS data  
 
Figure 8 CLS analyses of sample mix B at start and end of recommended trial period 
 
From these result it can be seen that although there was some limited variation in the relative 
quantities of the nominally 50 and 100nm materials but that there was no serious degradation with 
the material retaining a clear bimodal distribution.  
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7 Results obtained during method optimisation 
As previous discussed the participants were provided with a series of silver nano-particle pseudo 
standards which were to be used by each participant to optimise and verify the separation process 
developed for their own specific combination of apparatus. This was to be done in 4 steps. 
 Evaluation of effective separation from void peak 
 Evaluation of 10/40nm peak separation by quantitative determination of resolution 
 Evaluation of 40/100nm peak separation by quantitative determination of resolution 
 Evaluation of 20/60nm peak separation by quantitative determination of resolution 
 The following sections will illustrate the results obtained in each of these steps.  
The analysis of the unknown samples A and B to determine size and concentrations will be fully 
detailed in the successive chapter where both the data and the statistical analysis will be presented. 
7.1 Evaluation of effective separation from void peak 
The first stage in the method optimisation was to verify that the peak of the 10 nm silver particles 
could be adequately separated from the void peak. To evaluate the effectiveness of this separation 
the capacity factor k was calculated according to the formula below  
k’(AgNP10) = (tR(AgNP10) – tV(void peak)) / tV (void peak) 
In this study an adequate level of separation was consider to be achieved when the value of k was 
greater than 0.6. The numerical results calculated by the participant laboratories were collated and 
can be seen in the Figure 9 which shows that all but 2 laboratories achieved a capacity factor which 
was at or above the required value of 0.6.  
 
Figure 9 Reported capacity factor k for separation of void peak and nominal 10nm  
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7.2 Evaluation of 10/40nm peak separation by quantitative determination of resolution 
The second stage of the optimization process required that the cross flow profile be adjusted to 
achieve certain minimum levels of peak separation when using sample mixtures of known particle 
size. To assess this it was requested that the degree of separation of mono-dispersed species be 
determined by calculating the peak resolution from experimental data. The resolution of two 
species, A and B, is defined as 
 
Where W is the peak width at the peak base and tR is the retention time of peaks A and B. Baseline 
resolution is considered to have been achieved when the value of R is great than or equal to 1.5.  
The first sample in the optimisation was the trimodal mixture containing particles with size 10nm, 
40nm and 100nm.  From the fractograms obtained using UV detection it was requested that the 
resolution be calculated for the separation of the 10 and 40 nm peaks and then the 40 and 100 nm 
peaks. The numerical results obtained are shown in Figure 10 and Figure 11. 
 
 
Figure 10    Evaluation of 40/100nm peak separation by quantitative determination of resolution 
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Figure 11    Evaluation of 40/100nm peak separation by quantitative determination of resolution  
7.3 Evaluation of 20/60nm peak separation by quantitative determination of resolution 
The second stage of this part of the evaluation used a bimodal mixture of 20 and 60nm. In this case 
only one laboratory was able to clearly improve on this value while six were either at or slightly  
above the required value. 
 
 
Figure 12        Evaluation of 20/60nm peak separation by quantitative determination of resolution  
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and assess whether peak separation could be achieved. From high resolution CLS measurements it 
has been seen that these two materials are only just baseline separable and therefore would be a 
0
0.5
1
1.5
2
2.5
3
1 2 3 4 5 6 7 8 9
R
e
so
lu
ti
o
n
 
Laboratory No. 
R(AgNP 40/100) 
0
0.5
1
1.5
2
2.5
3
1 2 3 4 5 6 7 8 9
R
e
so
lu
ti
o
n
 
Laboratory No. 
AgNP20/60  
27 
challenging sample with which to evaluate the true separating capabilities of each optimised AF4 
system.  It was not generally expected that it would be possible to achieve baseline separation with 
the AF4 systems but an examination of the resulting elution curves could be used to verify the 
relative quality of separations achieved in in the trial compared to that of JRC. In this consideration a 
qualitative ranking of the separation relative to laboratory 1 was made and is shown in Table 7-1. 
The original elution curves as supplied by the participants are reproduced in Annex 1.  
Table 7-1 Qualitative assessment of AgNP40/60 separation  
Laboratory Separation achieved- relative to laboratory 1 
1 +/- 
2 - 
3 ++ 
4 + 
5 +/- 
6 +/- 
7 ++ 
8 +/- 
9 - 
 
7.5 Elution profiles resulting after the optimization process 
Following the previously described stages of optimization and verification it was possible for each 
laboratory to establish for themselves a single set of experimental parameters which were to be 
used in the rest of the analyses undertaken in the course of the ILC. The main parameters used in 
the optimised separation procedures of each laboratory are listed in Table 7-2. 
 
7.6 Time-Size calibrations obtained 
Using the previously described elution profiles the participant laboratories were requested to 
generate calibrations curves to correlate particle elution time with size. The calibration curves 
obtained can be seen in Figure 13. 
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Table 7-2 Elution profiles used by each laboratory after optimization 
Laboratory 
Injection 
Flow [mL/min] 
Injection/ Focusing 
Time [min] 
Detector Flow 
[ml/min] 
Initial Cross-
Flow [mL/min]* Elution profile 
1 0.2 5 0.5 1 
1 to 0.1 (linear 
decrease within   
40min then constant ) 
2 0.2 5 0.5 0.5 
Exp. decrease of cross 
flow from 0.5 ml/min 
to 0.1 ml/min 
3 0.2 7 1 1 
Linear 1 to 0.1ml/min 
in 30min 
4 1.5 5  1.5  
5 0.2 3  2  
6 0.2 5  1.5 
1.5- 0.1 linear 
decrease in 35 min 
then 10 min constant 
at 0.1 ) 
7 0.2 5 0.5 2  
8 0.2 5 0.5 1 1 constant 
9 0.2 3 0.5 1 
1 to 0.1 (linear 
decrease within   
40min then constant ) 
 
 
 
Figure 13 Calibration curves of size and elution time as reported by each laboratory  
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8 Analysis of unknown samples A and B 
To evaluate the effectiveness of the methodology, participants were requested to analyse two bi-
modal samples, each of which contained a mixture of two size(s) of silver nanoparticles in a 
concentration range between 100-1000 ng mL-1.  The samples were labelled “Unknown Sample A”, 
and “Unknown Sample B” and no information was provided about particle sizes or concentrations. 
“Unknown Sample A” had to be diluted 1:20 with ultrapure water prior to analysis, whereas 
“Unknown Sample B” was ready to be analysed without any dilution. 
8.1 Description of “Sample A” and “Sample B”  
 Unknown Samples A & B both contained two monodispersed particle sizes each1:  
 
Size 1: 52.4 nm  
Size 2: 99.4 nm 
 
The concentrations of these two particle sizes were chosen in order to represent a borderline case 
with respect to the definition of a nanomaterial (50% of particle number <100nm and 50% of particle 
number > 100nm). Due to the non-availability of particles with a size >100nm, particles with 99.4nm 
of diameter were considered to correspond to >100nm as this does not considerably change 
calculations). 
The diameters of the silver nanoparticles contained in the samples were to be calculated from the 
calibration curve previously prepared by plotting elution time against particle size. The 
concentration of the eluted silver fractions was to be determined with ICP-MS (either online or 
offline).  
8.1.1 Preparation Unknown Sample A: 
Exactly 21.35555g of the monodispersed AgNP(100nm)  standard (c=18.7 µg mL-1) and exactly 
2.59138 g of the monodispersed AgNP(50nm) standard (c=19.8 µg mL-1) were weighed into a 25 mL 
volumetric flask and brought to volume with ultrapure water.  
Concentrations in sample A were 15.97395 µg mL-1 of Ag(100nm) and 2.052373 µg mL-1 of Ag(50nm) 
respectively.  Aliquots of this solution were sent to trial participants labelled as “Unknown Sample 
A”. Sample A was to be used after a dilution of 1:20 which results in the following final 
concentrations. 
Sample A (diluted) 
c(AgNP50nm) =  103 µg L-1 
c(AgNP100nm) =  798 µg L-1 
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8.1.2 Preparation of Unknown Sample B: 
Exactly 2.48689 g of the undiluted “Unknown Sample A” solution were weighed into a 50 mL 
volumetric flask and brought to volume with ultrapure water. The resulting concentrations in sample 
B were therefore calculated to be the following 
Sample B (as supplied 
c(AgNP50nm) =  102 µg L-1 
c(AgNP100nm) =  795 µg L-1 
8.2 Determination of sizes and concentrations in “Unknown Samples” 
Participants of the current method performance exercise were asked to report both particle sizes 
and concentrations for “Unknown Sample A” and “Unknown Sample B”. Based on these results, a 
statistical evaluation was conducted.  
8.2.1 Reported values of concentration 
The concentrations of silver reported by each exercise-participant are shown in Table 8-1. The ICP-
MS data obtained by laboratory 7 are presented for completeness but have not been included in the 
statistical analysis which was performed only for the laboratories able to do the on-line analysis. 
 
Table 8-1     Concentrations (µg L-1) determined for “Unknown Sample A” and “Unknown Sample B” 
 Unknown Sample A
2 Unknown Sample B  
Laboratory 
Code 
AgNP 
(50 nm) 
AgNP 
(100 nm) 
AgNP 
(50 nm) 
AgNP 
(100 nm) 
Calibration Method 
Ref. values 103 798 102 795   N/A 
1a 103.9 863.7 73.1 742 Pre-channel with particles 
1b 76.1 631 58.3 575.6 Post channel with ionic silver 
2  185.7 368.6 131.7 663.3 Post channel with ionic silver 
3 106.9 398.6 109 544 Post channel with ionic silver 
4 42.6 400.3 32 397 Post channel with ionic silver 
5 72 680 63 750 Post channel with ionic silver 
6 N/A N/A N/A N/A  
7 14.3 
11.7 
243.9 
125.2 
--- 
17.1 
231.2 
258.5 
Off-line run 1 
Off-line run 2 
8* N/A N/A N/A N/A  
9 61.4 542.4 91 661 Post channel with ionic silver 
*Note: For technical reasons laboratory 8 was not able to undertake the analysis of the same samples A and B 
at the required time and was supplied with similar but not identical samples at a later date:  The results 
obtained were therefore not comparable and have not been included in the statistical evaluation. 
 
2
 Concentrations of the 1:20 diluted solutions are reported for “Unknown Sample A”  
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8.2.2 Data distribution  
Figure 14 to Figure 17 show the distribution of results obtained for the determination of 
concentrations of the two particle sizes in “Unknown Sample  A“ and “Unknown Sample B“. The dark 
blue lines represent the smoothed distribution of all test results; the light blue lines represent the 
cumulative distribution. 
 
Figure 14  Data distribution for “Unknown Sample A”, 50nm 
 
Figure 15 Data distribution for “Unknown Sample A”, 100nm 
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Figure 16 Data distribution for “Unknown Sample B”, 50nm 
 
Figure 17 Data distribution for “Unknown Sample B”, 100nm 
Although not perfectly symmetric, the data are sufficiently normally distributed to perform 
statistical analysis according to ISO 5725.  
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8.2.3 Outlier Tests 
Data has been tested for outliers (Grubbs and Cochran). No outlier has been identified. 
8.2.4 Statistical Parameters according to ISO 5725-2* 
Results for some of the principal statistical parameters are shown in Table 8-2 
 
Table 8-2 Results of selected statistical parameters 
 Unknown Sample A Unknown Sample B 
 
 AgNP(50 nm) AgNP(100 nm) AgNP(50 nm) AgNP(100 nm) 
 
Unit µg mL
-1
 µg mL
-1
 µg mL
-1
 µg mL
-1
 
No. of labs that submitted results 7 7 7 7 
Mean 92.6 554.9 79.7 618.9 
Reference Value 103 798 102 795 
s.d. 46.8 182.5 33.5 124.3 
Rel. s.d. 50.6 33.0 42.1 20.1 
Limit of reproducibility, R(2.80 x sR) 131.181 511.199 93.886 348.239 
Standard Error 17.708 69.005 12.673 47.008 
Lower confidence limit of LPOD 57.241 416.932 54.382 524.970 
Upper confidence limit of LPOD 128.073 692.954 105.075 713.001 
Outliers - - - - 
 
*ISO 5725-2:1994 Accuracy (trueness and precision) of measurement methods and results -- Part 2:  
Basic method for the determination of repeatability and reproducibility of a standard measurement 
method 
The following charts (Figure 18 to Figure 21) represent the raw data, plotting laboratory-
identifications on the x-axis and determined concentrations on the y-axis. Values are plotted in 
ascending order. The blue dotted line represents the mean concentration, the green lines the 
standard deviations and the red line the theoretical reference value (the “real” value). 
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Figure 18  Unknown Sample A – AgNP(50nm) 
 
Figure 19  Unknown Sample A – AgNP(100nm) 
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Figure 20  Unknown Sample B – AgNP(50nm) 
 
 
Figure 21  Unknown Sample B – AgNP(100nm) 
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8.2.5 Discussion of mean concentration values obtained 
Table 8-3 shows the comparison between the mean concentration values obtained from the 
participating laboratories with the theoretical calculated value (Ref. Value, red line) 
 
Table 8-3 Comparison of mean concentrations with reference values 
 Mean Concentration 
[ng mL-1] 
Reference Concentration 
[ng mL-1] 
Difference 
 
Unknown Sample A, 
50nm 
92.6 103 -10 % 
Unknown Sample A, 
100nm 
554.9 798 -30 % 
Unknown Sample B, 
50nm 
79.7 102 -21 % 
Unknown Sample B, 
100nm 
618.9 795 -22 % 
 
The following trends are observed: 
 In the majority of cases, the concentrations determined within this exercise are lower 
compared to the reference values.  
Based on indications given in the SOP provided, calibration/quantification was in almost all cases 
done post-channel against ionic silver. One laboratory however quantified both post-channel with 
ionic silver (Lab 1b) and pre-channel with particles (Lab 1a). Results (Table 8-4) show that pre-
channel calibration lead to a much better apparent recovery rates indicating that some material loss 
occurs in the channel.  
Table 8-4 Recovery rates in % comparing results calibrating pre-channel with particles and post-
channel with ionic silver 
 Post-channel calibration with 
ionic silver 
Pre-channel calibration with 
particles 
Unknown Sample A, 50nm -26 % + 0.8 % 
Unknown Sample A, 100nm -21 % + 8 % 
Unknown Sample B, 50nm -43 % - 29 % 
Unknown Sample B, 100nm -28 % - 7 % 
 
 The recovery for the 50 nm particles is better in “Unknown Sample A” 
The reason for this might be attributed to the fact that “Unknown Sample A” has been dispatched as 
a 20 times more concentrated solution, which had to be diluted prior to analysis. Smaller particles in 
the diluted (ready-to-inject) “Unknown Sample B” may have undergone a partial dissolution. To 
minimise this effect in future exercises solutions should be dispatched as a concentrate which has to 
be diluted prior to analysis. 
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 The recovery for the 100 nm particles is slightly better in “Unknown Sample B” 
 
 Recoveries for particles of 50 nm in size are better than for particles of 100 nm  
This might be attributed to the peak shape of silver nanoparticles of 100 nm in size. The wide peak-
broadening leads to less precise integration/quantification. 
These four major trends are further supported statistically by calculating the z-scores. 
8.2.6 Assessment of the performance of individual laboratories via z-scores 
Z-Scores are based on the deviation of the laboratory mean value from an assigned value (in our 
case the absolute calculated concentration). The z-score values were calculated as follows-  
Z scores = (Lab result – Theoretical Value) / s.d. 
Z-scores calculated for this method validation exercise are shown in Figure 22. 
 
 
Figure 22 Z-scores for assessment of laboratories performance 
 
8.2.7 Discussion of z-values 
Values between -2 and +2 are considered “acceptable”. The lower the absolute z-score value, the 
closer the lab result is in relation to the theoretical value. Negative bars in Figure 22 indicate that the 
determined value is lower compared to the theoretical reference value. Positive bars indicate that 
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the determined value is higher compared to the theoretical reference value. The calculated z-scores 
confirm what has already been discussed previously. 
8.3 Statistical evaluation of determined particle sizes  
8.3.1 Reported values for size 
Particle sizes determined by exercise-participants are shown in Table 8-5. The reference values for 
the two materials were the following: 52.4 nm and 99.4 nm 
 
Table 8-5  Particle sizes determined for “Unknown Sample A” and “Unknown Sample B” 
 Unknown Sample A (*) Unknown Sample B (*) 
Laboratory Code AgNP(50) AgNP(100) AgNP(50) AgNP(100) 
 
1 53 100 53 100 
2 50.1 111.2 64.9 117.8 
3 54 106 55 105 
4 52 106 70 109 
5 50 100 60 115 
6 50 100 80 100 
7 49.8 110.9 55 113.5 
8 N/A N/A N/A N/A 
9 47 180 50 160 
 
 
*Particle sizes are expressed in nm 
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8.3.2 Data distribution  
Figure 21 to 24 show the distribution of results obtained for the determination of particles‘ size in 
“Unknown Sample A“ and “Unknown Sample B“. The dark blue lines represent the smoothed 
distribution of all test results while the light blue lines represent the cumulative distribution.  
 
Figure 23 Data distribution for “Unknown Sample A”, 50nm 
 
Figure 24 Data distribution for “Unknown Sample A”, 100nm 
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Figure 25 Data distribution for “Unknown Sample B”, 50nm  
 
Figure 26 Data distribution for “Unknown Sample B”, 50nm 
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8.3.3 Outlier Tests 
Data has been tested on outliers (Grubbs and Cochran). The following two values have been 
identified as outliers: 
Lab 9, Unknown A, 100nm (data point = 180 nm) 
Lab 9, Unknown B, 100nm (data point = 160 nm) 
These two data-points have not been considered for the statistical evaluations. 
8.3.4 Statistical Parameters according to ISO 5725-2 
Results for some of the principal statistical parameters are shown in Table 8-6 
 
Table 8-6   Results of selected statistical parameters 
 Unknown Sample A Unknown Sample B 
 50 nm 100 nm 50 nm 100 nm 
Unit nm nm nm nm 
No. of labs that submitted results 8 8 8 8 
Mean 50.74 104.87 60.99 108.61 
Reference Value 52.4 99.4 52.4 99.4 
s.d. 2.194 5.002 10.108 7.195 
Rel. s.d. 4.32 4.77 16.57 6.62 
Limit of reproducibility, R(2.80 x sR) 6.144 14.006 28.303 20.147 
Standard Error 0.776 1.891 3.574 2.720 
Lower confidence limit of LPOD 49.186 101.09 53.84 103.175 
Upper confidence limit of LPOD 52.289 108.653 68.135 114.054 
Outliers - 1 
7 valid results 
- 1 
7 valid results 
 
The following charts (Figure 25 to 28) represent the raw data for both samples/particle sizes, 
plotting laboratory-identifications on the x-axis and determined particle size on the y-axis. Values are 
plotted in ascending order. The blue dotted line represents the mean particle size, the green lines 
the standard deviations and the red line the theoretical reference value (the “real” value). 
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Figure 27 Unknown Sample A – 50nm 
 
Figure 28 Unknown Sample A – 100nm 
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Figure 29 Unknown Sample B – 50nm 
 
Figure 30 Unknown Sample B – 100nm 
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The comparison of the mean particle sizes of all results obtained by the participating laboratories 
with the theoretical value (Ref. Value, red line) is shown in Table 8-7. 
 
Table 8-7 Comparison of mean particle sizes with reference values 
 Mean Size 
[nm] 
Reference Size 
[nm] 
Difference 
 
Unknown Sample A, 50nm 50.7 52.4 -3.2 % 
Unknown Sample A, 100nm 104.9 99.4 +5.5 % 
Unknown Sample B, 50nm 61.0 52.4 +16.4 % 
Unknown Sample B, 100nm 108.6 99.4 +9.3 % 
 
The following trends are observed: 
 In 7 out of 8 cases, the size determined for “Unknown Sample B, 50nm” is higher compared 
 to the same particle type in “Unknown Sample A” 
 The size determined in “Unknown Sample B, 50nm” is around 10nm too high. 
 The size determined in “Unknown Sample A, 50nm” is very accurate 
 The size determined in “Unknown Sample A, 100nm” is sufficiently accurate 
 The size determined in “Unknown Sample B, 100nm” is less accurate compared to 
 “Unknown Sample A” of the same size 
In general, the results indicate that particles in the ready-to-inject sample (Unknown Sample B) have 
undergone an increase in diameter. The reason might be attributed to a less stable colloidal 
suspension which has undergone some degree of aggregation. In any future exercises the samples 
should be dispatched as a concentrate which needs to be diluted prior to analysis. 
The five major trends listed above are further supported statistically by calculating the z-scores. 
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8.3.5 Assessment of the performance of individual laboratories via z-scores 
Z-Scores are based on the deviation of the laboratory mean value from an assigned value (in our 
case the absolute declared particle size). 
Calculation z-scores: 
 
Z scores = (Lab result – Theoretical Value) / s.d. 
 
Z-scores calculated for this method validation exercise are depicted in Figure 31 
 
 
Figure 31  Z-scores for assessment of laboratories performance 
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8.3.6 Discussion of z-scores 
Values between -2 and +2 are considered “acceptable”. The lower the absolute z-score value, the 
closer the lab result is in relation to the theoretical value. Negative bars in figure 18 indicate that the 
determined value is lower compared to the theoretical reference value. Positive bars indicate that 
the determined value is higher compared to the theoretical reference value. 
The calculated z-scores confirm what has already been mentioned in the previous sections 
Size determination for the 100 nm particles done by laboratory 9 in both “Unknown Samples A & B” 
have by far exceeded the reference values. The reason should be further investigated. 
8.4 Concluding Remarks 
The proposed methodology was assessed in an unbiased manner by asking participants to analyse 
two “unknown” samples each. One sample had to be diluted before analysis and the other was 
ready to inject. The diluted and the ready-to-inject sample were composed of the same particles and 
had the almost the same final concentrations of silver. Concentrations of the two particle sizes were 
adjusted to represent a “borderline” case in regard to the definition of nanomaterials (50% of the 
number of particles < 100 nm and 50% above 100 nm). 
Results obtained in this restricted method performance exercise have provided the data necessary 
to make a preliminary assessment of the precision achievable with the technique. Table 8 lists the 
theoretical values along with the measured mean value and their respective standard deviations for 
“Unknown Sample A” which yielded better results. 
 
Table 8-8 Theoretical values compared to measured mean values and their respective standard 
deviations obtained in this exercise (Only “Unknown Sample A”). 
 Concentration 
[ng mL-1] 
Particle Size 
[nm] 
 Theoretical 
Value 
Mean Value S.D. Theoretical 
Value 
Mean 
Value 
S.D. 
“Unknown Sample A” 
50nm 
103 92.7 ± 46.8 52.4 50.9 2.2 
“Unknown Sample A” 
100nm 
798 554.9 ± 182.6 99.4 104.3 4.9 
 
Trueness (accuracy) and especially precision of the quantification does not allow a clear 
identification of whether a particle mixture is or is not a nanomaterial under borderline conditions 
according to the definition. The accuracy and precision of particle size-determination however are 
satisfactory. 
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Table 8-9 shows how accuracy and precision of concentrations determined in this exercise influence 
the identification/non-identification of a nanomaterial by converting mass concentrations into the 
number of particles. 
 
Table 8-9 Conversion of measured mass concentrations into corresponding number of particles 
Case cAgNP50 
[ppb] 
cAgNP100 
[ppb] 
Ratio 
#(AgNP50)/ 
#(AgNP100) 
#(AgNP)<50nm 
[%] 
Nanomaterial 
according to 
definition? 
Theoretical Concentrations 103 798 1.03 51 Yes 
Mean Concentration of 
current method performance 
exercise 
92.7 554.9 1.34 57 Yes 
1
st
 extreme 
 
AgNP50nm 
Mean Conc. 
+SD 
 
AgNP100nm 
Mean Conc. 
-SD 
139.5 372.3 3.00 75 Yes 
2
nd
 extreme 
 
AgNP50nm 
Mean Conc. 
-SD 
 
AgNP100nm 
Mean Conc. 
+SD 
45.9 737.5 0.50 33 No 
 
How could the methodology be improved? 
 The use of pre-channel calibration with silver nanoparticles has shown to be able to 
significantly improve precision and trueness. The use of silver particles for this type of 
calibration is however limited by the lack of availability of such particles across the necessary 
size range and the absence of certified materials (certified for size and concentration). 
 In the current exercise not all participating laboratories used exactly the same instrumental 
setup. Most used an online combination of AF4-ICP-MS. Some however did use other 
combinations. The method’s performance is likely to increase if all laboratories use exactly 
the same instrumental setup. 
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9 Future work  
The study which has been detailed in this report was undertaken as a first stage evaluation of AF4-
ICPMS methodologies for measuring nanoparticle mass and number size distributions. The results 
have shown the basic separation methodology to be promising but the mass quantification by ICP-
MS has shown less than ideal behaviour.  From this study it has been possible to identify number of 
key areas for improvements as detailed below. These improvements cover not only the basic 
practice of the separation process but also the stability of the particles under test and the 
membrane materials used in the separation.  
9.1 Dynamic range of AF4 separations 
The study has shown that the separation methodology is relatively effective and reproducible over 
the range of particle sizes considered in this study i.e. 10nm to 100nm. For the particular application 
considered in this work, Ag nanoparticles, this range would normally cover a large portion of the size 
range relevant to silver based nanomaterials but for strict application to the definition this range is 
not sufficiently large.  
a) Lower limit: The method has been developed to ensure that there is void peak 
separation of particles to below 10nm but as the definition requires information on size distributions 
to 1nm. It is likely that this issue could be resolved by increasing the analysis cross-flow but in order 
to reach 1nm the high cross-flow required is likely to result in loss of larger particle by absorption 
onto the accumulation wall 
b) Upper limit: The current verified upper limit of around 110-120nm could be extended by 
decreasing the cross-flow but this would likely lead to the loss of the smaller particles into the void 
peak. 
The most likely way of resolving these two contradictory problems would be to analyse each sample 
using 2 or 3 different elution profiles each of which has been specifically optimised to operate 
efficiently in different specific narrower but overlapping size ranges. Eg. (1nm-60nm) and (30nm to 
300nm) and (50nm to 500nm).  
9.2 Quantification ICP-MS  
In the study is apparent that the quantification of the silver mass by ICP-MS did not give adequately 
accurate or reproducible results. The origin of these results is likely due to a combination of several 
issues including the lack of any single standardised calibration method, variability in column recovery 
and also the possible degradation of the samples particularly when the participating laboratories had 
not been able to respect the time scale requested.  
Approaches to improving these problems could the following 
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a) Specify a more detailed methodology for the calibration of the ICP-MS system with respect 
to the AF4 column. One method could be the use of pre-column injection of nanoparticle standards 
which has been found by JRC to give the most accurate and reproducible method. This method, 
though technically promising, has the disadvantage that it is bound by the availability of accurately 
characterised standards of the same/similar materials to the samples being analysed. These 
requirements may be difficult to satisfy in the real-world situation particularly when having to 
analyse other samples from families of materials where not even pseudo-standards can be sourced. 
b) In the case where pre-column injection of nanoparticles is not used 
calibration/quantification using isotope dilution method would be a powerful method to resolve 
some of the difficulties with silver nanoparticle analysis by ICP-MS. This method could be 
implemented for silver but for other types of nanomaterials its application would depend on the 
availability of suitable, stable isotope materials.     
c) The use of more chemically stable silver nanoparticles (eg. stabilised by PVP or PEG) would 
permit further evaluation studies to be conducted with less influence of materials degradation. This 
would be relevant only to ring-trial studies and would not be a solution to the analysis of unknown 
silver samples. 
9.3 Applicability of the method to alternative types of silver particles  
The ILC has concentrated very specifically on one common type on silver nanoparticle, citrate 
stabilised, but this is only one of several types likely to be found in commercial products. Under ideal 
condition the use of AF4 requires that there be no significant electrostatic or chemical interaction 
between the particle and the accumulation wall. Unfortunately this is difficult to ensure in practice 
as it would be undertake a detailed optimisation process for each new type of particle. This problem 
is one of the most difficult which must be tackled  
a) A partial solution to the problem would be to verify the correct functioning of the existing 
method for other common types of particle stabilisation such as PEG, PVP, tannic acid and other 
neutral/negatively charged stabilizers.  
b) In the case that the existing method proves to be insufficiently generic it would be necessary 
of search for alternate conditions of membrane/eluent/pH/surfactant which can more widely 
applied.  
9.4 Application of DLS for on-line nano-particle sizing 
A major issue in developing the methods for simultaneously quantifying materials mass and size is 
that particle size determination depends on having suitable standards and the assumption that any 
calibrations standards will behave like the actual analyte particles. In this study this was the case but 
in real-world testing this is more difficult to guarantee.  The ideal solution to this would be to 
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eliminate the need for particle size standards and obtain information on particle sizes by direct 
measurement online by DLS.  This solution, although elegant does have the problem of the 
sensitivity of DLS when analysing very small or poorly scattering particles types.  The implementation 
of this solution would require careful examination of the materials concentrations required to obtain 
acceptable DLS performance in the particle size range of 1-20nm.   
9.5 Mass-number distribution conversion: reliability of methodology  
The ultimate goal of this activity is to arrive at a number size distribution by mathematical 
conversion of data in the form of a mass-size distribution. This is a process which may introduce 
large errors as particle size approaches the lower limit of the definition and it will be very important 
to quantify the level of errors in respect of the requirement of the definition.  
9.6 Control of eluent pH  
The eluent which was recommended in this work was high purity water modified only with a small 
amount of NaOH to adjust the pH to 9.4 with additional stabilising buffer being added. One 
participating laboratory did note that during a day of measurement the pH of the eluent solution 
decreases excessively (by absorption of atmospheric CO2) and that this could modify the retention 
times. Although the variation of retention time with pH has been noted during method 
development, in practice, the typical change the pH found (<0.2 pH units in 2 litres of fresh eluent) in 
the JRC laboratories was insufficient to create any problem and so was not taken into consideration 
in the SOP. In future work it may be advisable to avoid the risk of this problem by considering the 
addition of a small quantity of a buffer agent to counteract the effect of CO2 absorption. A suitable 
reagent for this purpose would be a small quantity (0.1-0.5mM) of (NH4)2CO3 as discussed in the 
work by Loeschner et al [7]. 
9.7 Quality control of membranes 
One final issue which has been noted in this study is that membrane quality can have a strong 
influence on the effectiveness of the separations achievable. This is a problem which can only be 
resolved by the materials suppliers but for the purposes of future study this problem should be 
avoided by supplying participants with materials from a single batch of membranes. 
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10 Overall summary and conclusions 
The Nanobiosciences and Chemical and Testing Units of the Joint Research Centre’s Institute for 
Health and Consumer Protection have been collaborating on the development of methods for 
measuring nanoparticle number size distributions in support of the implementation of the European 
commission recommended definition of a nanomaterial.  
As part of this activity a method which combines a particle size separation (Asymmetric Flow Field 
Flow Fractionation (A4) step and a particle detection/quantification step (Induction Coupled Plasma-
Mass Spectrometry (ICP-MS)) has been examined and optimised experimentally for use in the 
analysis of aqueous dispersed silver nanoparticles. Following an internal validation, the method has 
been documented in the form of a Standard Operating Procedure (SOP) designed to provide all the 
necessary information to allow the method to be applied by suitably equipped external laboratories. 
To verify the transferability of the method an international ring-trial was organized by JRC in which 8 
independent laboratories were provided with detailed documentation and suitable test materials to 
allow them to test the transferability of the SOP.  
The results obtained have led to the following main conclusions 
1) The separation methodology, when applied with the reference standards was found to be 
transferable to different laboratories with all laboratories being able to separate the recommended 
mixtures of mono-dispersed materials. A possible improvement to the separation methodology 
which may be considered would be the addition of a low concentration of a pH buffer to the eluent.     
2) In the course of the study it was found that two laboratories reported problems of 
separation resulting from the quality of the separation membranes. Substitution of membrane with 
that from alternate batches or alternate manufacturers was found to resolve the problem. It should 
be noted that during method development this problem has also been observed by the organizing 
laboratory (JRC) although during the laboratory trial the problem was not observed.  
3) The separation methodology, when applied with the “unknown samples A and B” and using 
UV absorption detection showed five of nine laboratories as being able to clearly separate the 
bimodal mixture. Three of the nine laboratories were able to obtain elution curves which showed 
evidence of the two peaks but with poor signal/noise ratio. Only one laboratory was not able to 
show evidence of the bimodal mix. 
4) A statistical analyses of the result obtained from the unknown samples showed that 
acceptable accuracy and reproducibility was obtained for the measurement of nanoparticle size but 
that the quantification of the amount of silver using the ICP-MS was not sufficiently accurate or 
reproducible.  
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5) Sample stability: It is known that silver nanoparticles often exhibit problems of stability and 
may suffer from aggregation or dissolution during long term storage. A number of the participants 
were not able to complete their analyses in the recommended time period and it is likely that this 
may have influenced negatively on the quality of results obtained. 
It should be noted that prior to initiating the inter-laboratory trial a series of studies were conducted 
by JRC to evaluate the useful shelf life of the nanoparticle mixtures. The results showed that dilute 
mixtures similar to the unknown samples A and B when correctly stored do not change more than 
10% over 4 weeks. Since the test recommended that measurement be conducted within 4 weeks of 
receiving the material no major deterioration in the samples was expected.  To further verify this a 
series of additional samples prepared together with those used in the  ring trial were stored at JRC 
and analysed periodically during the 4 week time period specified for the study. The results obtained 
confirmed that no serious deterioration of the pseudo-standards or the unknown samples A/B 
samples had occurred over the period of the trial. It should be noted that this evaluation does not 
take into account the possible deterioration during transport or as result of non-ideal storage and 
handling.  
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Annex 1: Elution curves of 40nm:60nm mix 
 
Figure 32  Laboratory 1 Elution curves of 40nm:60nm mix 
 
 Figure 33 Laboratory 2 Elution curves of 40nm:60nm mix 
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Figure 34  Laboratory 3 Elution curves of 40nm:60nm mix 
 
 
 
Figure 35 Laboratory 4 Elution curves of 40nm:60nm mix 
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Figure 36 Laboratory 5  Elution curves of 40nm:60nm mix 
 
 
 
Figure 37 Laboratory 6 Elution curves of 40nm:60nm mix 
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Figure 38 Laboratory 7 Elution curves of 40nm:60nm mix  
 
 
Figure 39 Laboratory 8 Elution curves of 40nm:60nm mix 
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Figure 40 Laboratory 9 Elution curves of 40nm:60nm mix 
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Annex 2: Elution curves from UV and ICPMS of unknown samples A and B
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Figure 41 ICP-MS and UV Results from Lab 1  
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Figure 42 ICP-MS and UV Results from Lab 2 
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Figure 43 ICP-MS and UV Results from Lab 3 
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Figure 44 ICP-MS and UV Results from Lab 4 
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Figure 45 UV Results from Lab 5 ICP-MS DATA not available 
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Figure 46 UV Results from Lab 6 ICP-MS DATA not available 
0.0100
0.0105
0.0110
0.0115
0.0120
0.0125
0.0130
0.000 10.000 20.000 30.000 40.000 50.000 60.000
U
V
-V
is
 D
e
te
ct
o
r/
a.
u
.  
Elution time/min 
 
Sample (A) Abs Lab 6 
0.0080
0.0085
0.0090
0.0095
0.0100
0.0105
0.0110
0.000 10.000 20.000 30.000 40.000 50.000 60.000
U
V
-V
is
 D
e
te
ct
o
r/
a.
u
.  
Elution time/min 
Sample (A) Abs Lab 6 Rpt 
0.0090
0.0095
0.0100
0.0105
0.0110
0.0115
0.0120
0.000 10.000 20.000 30.000 40.000 50.000 60.000
U
V
-V
is
 D
e
te
ct
o
r/
a.
u
. 
Elution time/min 
Sample (B) Abs Lab 6  
0.0085
0.0090
0.0095
0.0100
0.0105
0.0110
0.000 10.000 20.000 30.000 40.000 50.000 60.000
U
V
-V
is
 D
e
te
ct
o
r/
a.
u
. 
Elution time/min 
Sample (B) Abs Lab 6 Rpt 
66 
    
Figure 47 UV Results from Lab 7 
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   Sample A          Sample B 
Figure 48 UV and BATCH ICP-MS Results from Lab 7 
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Figure 49 ICP-MS and UV Results from Lab 8 
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Figure 50 ICP-MS and UV Results from Lab 9 Only sample A with replicate (Sample B not measured) 
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Annex 3: Elution curves of trimodal mixture (20nm-40nm-80nm) using UV detection 
  
   
Figure 51 Labs 1-4Eelution curves of trimodal mixture   
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Figure 52 Labs 5-8 Elution curves of trimodal mixture  
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Figure 53 Lab 9 Elution curves of trimodal mixture 
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Annex 4: Summary of AF4-ICP-MS (off-line data) from laboratory 7 
Participant Laboratory No.7 was not equipped with ICP-MS online but instead did sample 
fractionation with later analysis off-line. The samples for off-line analysis by ICP-MS were collected 
as 1ml fractions at a collection rate of 0.5ml/min. Analysis were conducted in a collaborator 
laboratory following the ICP-MS procedure described below. It should be noted that number of 
samples which could be analysed was limited and consequently not all runs could be fully evaluated 
nor could the repeatability be fully evaluated. 
This method of analysing the nanoparticle size distribution was not foreseen in the current version 
of the SOP but the results obtained have been included in this report as they provide information on 
an alternative measurement strategy for laboratories where there is not the possibility of directly 
coupling of ICP-MS and AF4. 
Description of procedure used to calibrate ICP-MS response to silver, sample preparation for 
offline ICP-MS measurements 
 Direct calibration before offline measurements with: blank, 0.1, 0.2, 0.5, 1.0 and 2.0 µg/L 
Silver (in 1% Nitric acid, suprapur)  
 Extern calibration with SRM 1643e, 1.036 µg/L Ag 
 Intern standard: Rh, 30 µg/L 
 Ionic silver standard solution (stock concentration 1g/L, supplier: Merck) 
 Detection: 107Ag, nogas-mode 
 LOD for offline measurements: 0.05 µg/L (values < 0.05 µg/L are not given in the data 
evaluation) 
 AF4-fractions: 1 mL  ICP-MS measurement value: mean of 2 minutes elution time 
 Sample preparation: After AF4-run: Add 100 µl 65% nitric acid (suprapur), after at least 30 
min diluting with ultrapure water  total sample volume = 10 mL  1:10 dilution 
 10/40/100-mix: AF4 run on 30.4.2013, ICP-MS measurement on 2.5.2013 
 20/60-mix: AF4 run on 30.4.2013, ICP-MS measurement on 2.5.2013 
 40/60-mix: AF4 run on 30.4.2013, ICP-MS measurement on 2.5.2013     fraction volume 
was too high to analyse two separated particle peaks ( collecting smaller fractions would 
be better) 
 Sample A: AF4 run on 6.5.2013, ICP-MS measurement on 17.5.2013 
 Sample B: AF4 run on 6.5.2013, ICP-MS measurement on 17.5.2013 
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Additional Information and remarks: 
 ICP-MS measurements could not be carried out immediately after the AF4 runs, time offset: 
between  3 and 11 days (the samples were stored in the dark at room temperature – no 
freezing) 
 The sample preparation of AF4 fractions should be optimized in the future.  The samples 
prepared for ICP-MS were not very stable (although the silver was dissolved in conc. nitric 
acid)  later measurements of the same sample gave different results (less silver content)  
 Delay between AF4 signals (peaks) and ICP-MS signals (peaks) is because of the delay time 
between the AF4 detector and the fraction collector. The time offset of the ICP-analysis in 
the fraction can be clearly seen compared to the UV signal  
 The analysis of the silver content of the unfractionated samples were in good agreement 
with the calculated silver concentration 
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Figure 54 AF4-ICP_MS (off-line data) obtained from 10,40,100nm mixture 
 
 
 
Table AA-1 Quantified AF4-ICP_MS (off-line data) obtained from 10-40-100nm mixture 
 Measured/ng Expected/ng Recovery(%) 
    
first peak 23.7 31.9 74.3 
second peak 26.5 32.9 80.5 
third peak 18.7 33.7 55.5 
Total 68.9 98.5 69.9 
 
 
0
2
4
6
8
10
12
-0.003
-0.0025
-0.002
-0.0015
-0.001
-0.0005
0
0.0005
0.001
0.0015
0 5 10 15 20 25 30 35 40 45 50
si
lv
e
r 
co
n
te
n
t 
[n
g]
 
D
e
te
ct
o
r 
Si
gn
al
 [
V
] 
Time [min] 
Fractogramm - 10-40-100nm  Mix 
UV 420 nm [V] offline ICP-MS measurements
76 
 
Figure 55 AF4-ICP_MS (off-line data) obtained from 20-60nm mixture 
 
 
Table A4-2  Quantified AF4-ICP_MS (off-line data) obtained from 10,140,100nm mixture 
 Measured/ng Expected/ng Recovery(%) 
    
first peak 22.9 34.4 66.6 
second peak 11.6 34.9 33.2 
Total 34.5 71.30 48.4 
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Figure 56 AF4-ICP_MS (off-line data) obtained from 40, 60nm mixture 
 
Table A4-3  Quantified AF4-ICP_MS (off-line data) obtained from 40-60nm mixture 
 Measured/ng Expected/ng Recovery(%) 
first peak no peak separation 32.9 -- 
second peak no peak separation 34.9  
Total 50.6 59.70 84.8 
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Figure 57 AF4-UV obtained from Unknown Sample A 
 
Figure 58 AF4-ICP-MS (off-line data) obtained from Unknown Sample A 
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Figure 59 AF4-UV obtained from Unknown Sample B 
 
Figure 60 AF4-ICP-MS (off-line data) obtained from Unknown Sample B 
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Table A4-4 ICP-MS off-line results obtained for unknown samples A and B  
  
Measured/ng Expected/ng* Recovery(%) 
Sample A Run 1 first peak 0.64 4.64 13.88 
 
second peak 10.98 35.91 30.57 
 
Total 11.62 40.55 28.66 
     Sample A Run 2 first peak 0.53 4.64 11.36 
 
second peak 5.64 35.91 15.69 
 
Total 6.16 40.55 15.20 
     Sample B Run 1 first peak Not resolved 4.59 - 
 
second peak 10.40 35.78 29.08 
 
Total 10.40 40.37 25.77 
     Sample B Run 2 first peak 0.77 4.59 16.78 
 
second peak 11.63 35.78 32.51 
 
Total 12.40 40.37 30.72 
 
*Expected values are calculated assuming an injected sample volume of 45µl and AgNP 
concentrations which correspond to those noted below (reproduced from the description of samples 
A and B given in section 8.1.) 
  
 
Table A4-5 Mass concentrations of particles in unknown samples A and B 
Unknown Sample Conc. Particles of 50nm Conc. Particles of  100nm 
A 103 µg L-1(4.64ng/45µl) 798 µg L-1 (35.91ng/45µl) 
B 102 µg L-1(4.59ng/45µl) 795 µg L-1(35.78ng/45µl) 
 
 
Considerations of the AF4-ICP-MS (off-line data) 
The results obtained from the sample mixtures prepared from the undiluted mono-dispersed 
pseudo- standards show recovery values which are the range 55-80% and therefore consistent with 
levels of recovery routinely found with detection by UV alone. In particular the results obtained 
(Figure 54) with the tri-modal mix of 10,40 and 100nm particles show promise where the peak 
resolution required is more compatible with the eluent sampling frequency and volumes.   
In contrast to this the ICP-MS results obtained with the unknown samples A and B are all below the 
50% level which is lower than would have been expected.  In considering these results a number of 
technical issues should be noted. 
a) The samples A and B, as previously described were designed to simulate a bimodal particle 
distribution which is close to the nano/non-nano limit (50% particle number below 100nm) 
established by the EU definition. To simulate this ratio and maintain total concentration levels 
comparable with the method development exercises the mass concentration of particle of 50nm had 
to be reduced to a level which can be challenging to accurately quantify by ICP-MS. 
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b) In comparison to the sample mixtures made from the stock solutions, the samples A and B 
were subjected to the additional uncertainty coming from sample aging which appears to have been 
a greater issue than was foreseen.   
c) The additional sample manipulation necessary for the completion of off-line analysis is likely 
to lead to higher loss of analyte material and in the particular case of Ag ions the mass loss through 
adsorption to contact materials (eg. vials/pipette tips) is known to be problematic. 
The severity of each of these issues could be reduced by using more concentrated samples or by 
injection larger sample volumes. In this way relative errors due to mass loss would be reduced and 
size resolution could be increased by permitting higher sampling frequency. 
Clearly the off-line methodology is unlikely to be able to compete directly with on-line 
measurements when using low concentration samples but as a strategy for use where direct 
coupling is not feasible these results  suggest that the method is worthy of further study using more 
concentrated samples.     
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Annex 5: SOP document distributed to ring-trial participants. 
 
Standard operating procedure for the inter-laboratory 
performance study: detection/quantification of silver 
nanoparticles in an aqueous matrix 
 
 
 
Stage 1: Preliminary study to assess the correct application of the method in participating 
laboratories 
 
 
 
Title: 
Identification and quantification of Ag nanoparticles in aqueous suspensions combining Asymmetric 
Flow Field Flow Fractionation and Inductively Coupled Plasma-Mass Spectrometry (AF4-ICP-MS) 
 
 
 
 
 
 
 
 
Version:  Final Version for trial distribution   
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1 Introduction 
In 2011 the European Commission[1], in response to a request from the European parliament, 
agreed on a common definition for the term nanomaterial which requires that materials be 
characterized in terms of the number size distribution of their constituent particles. Implementation 
of this definition within the context of legislative controls requires that enforcement laboratories be 
provided with fit-for purpose analytical methods.  
To address the analytical challenges and to provide valid technical input to potential legislators JRC-
IHCP has, on specific request from DG-SANCO, began a study program aimed at the development of 
methods which can be applied to the technical implementation of the above noted definition. The 
outcome of this study ideally would result in the publication of a validated test protocol applicable to 
at least one technically relevant type of liquid dispersed nanoparticle. 
As part of this activity a detailed study was undertaken by JRC to develop a specific method for the 
analysis of aqueous dispersed silver nanoparticles by use of combined Asymmetric Field Flow 
Fractionation (A4) and Induction Coupled Plasma-Mass Spectrometry (ICP-MS). This method has 
been now been developed into a simplified Standard Operating Procedure(SOP) which is detailed in 
this document.  The further development of this procedure towards becoming a validated test 
protocol now requires the method be evaluated by inter-laboratory ring-trials. 
Given the technical complexity of the problem, it has decided that the process of validating the SOP 
through inter-laboratory studies should be split in two stages: a method familiarization stage (Stage 
1) and the validation study itself (Stage 2). This document will detail the procedures to be followed 
for participants in stage 1 of this process  
 
Stage 1: Correct application of the method in participants’ laboratories (method familiarization) 
The first stage of this study is to assess whether the analysis procedures developed by JRC can be 
successfully transferred to other independent laboratories equipped with comparable but not 
necessarily identical AF4-ICP-MS facilities.  It is foreseen that the methodology be applicable by 
laboratories with existing experience of AF4 but not necessarily with experience of  the nanoparticle 
mixtures of the type being examined here. It will, therefore, be necessary that each laboratory 
optimize the instrumental conditions for their own combination of equipment. To do this, a series of 
mono-modal (near mono-dispersed) samples of declared size and concentration are supplied. For an 
evaluation of the final optimized conditions simple bi/tri-modal samples of undeclared size and 
concentration are supplied for analysis. The outcome of stage 1 will be discussed during a 
workshop shortly after its conclusion.  
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Note [1] COMMISSION RECOMMENDATION on the definition of nanomaterial (2011/696/EU) 
published in the Official Journal of the European Union on 20.10.2011:  L 275/38 
2 Scope and applicability of the method and SOP 
The procedure is applicable for the determination of electrostatically stabilized anionic silver 
nanoparticles with a particle size range 10-100 nm in ultrapure water. The method is based on on-
line coupling of the particle size fractionation method asymmetric flow field flow fractionation with 
Inductively Coupled Plasma-Mass Spectrometry (AF4-ICP-MS). 
3 Terms and definitions 
AgNP    Silver nanoparticles 
AgNP10, AgNP20…  Silver nanoparticles of nominal diameter of 10 nm, 20 nm…   
AF4   Asymmetric Flow Field Flow Fractionation 
UV/VIS   Ultraviolet/Visible 
ICP-MS   Inductively coupled plasma mass spectrometry 
ISTD   Internal standard 
DG SANCO  Directorate General for Health & Consumers –  
   European Commission 
DG JRC   Directorate General Joint Research Centre – 
   European Commission 
SOP   Standard Operating Procedure 
 
4 Principle of method 
The untreated sample, injected in the sample loop of an AF4 system is subjected to size fraction 
separation by means of AF4 with smaller particles eluting before larger ones (range 10-100nm). For 
detection and quantification of the size fractions, the AF4 is coupled online to an ICP-MS. 
When analysing unknown silver colloidal samples the size of nanoparticles is determined by 
calibrating the system for size against elution time using the supplied near mono-dispersed silver 
standards. For quantification of silver mass, the ICP-MS instrument response must be calibrated 
using appropriate silver reference solutions. This stage may be approached using methods already 
established in the participant’s laboratories or alternatively by following a method described later in 
section 7.5  
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5 Reagents 
The study program foresees the use of a series of chemical reagents which will not be supplied by 
JRC but which should be available in each participating laboratory. During the analysis only chemicals 
of recognized high purity analytical grade should be used. 
Water: Ultrapure (18 ohms resistivity) 
Sodium hydroxide solution (NaOH):  0.1M in ultrapure water 
Nitric acid, 67-69%: Ultrapure for trace analysis 
Ionic silver standard solutions:  Any commercially available certified ionic silver standard defined as 
being suitable for ICP-MS calibration 
Internal standard for ICP-MS:  Any commercially available certified ionic standard defined as being 
suitable for ICP-MS calibration may be used: Rhodium in nitric acid is recommended 
Eluent of the AF4 system:  Ultrapure water adjusted to pH 9.2 with diluted sodium hydroxide 
sodium hydroxide solution. The eluent shall be prepared freshly every day and shall be degassed 
before use. 
Acidifier solution for AF4 post-column eluent (pre ICP-MS): 5% Nitric acid-may contain 20 µg L-1 
Indium or Rhenium as a reference ion for dilution and flow monitoring. 
Washing solution for ICP-MS:  2-5% Nitric acid solution 
ICP-MS carrier gas:   Argon (99,9999%) 
Stock solutions of (mono-modal) silver nanoparticles:   Supplied by JRC containing near mono-
dispersed silver pseudo-standards[2] of citrate stabilized silver nanoparticles dispersed in aqueous 
sodium citrate solution. Nominal sizes range from 10nm to 100nm in 10nm steps. Concentrations 
and sizes are listed as follows in Table 1 
 
 
[2] Pseudo standards refer to mono-dispersed nano-particle materials supplied for calibration in this 
study. Materials were obtained from two different commercial sources referred to as 
Manufacturer(1) and Manufacturer(2). 
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Table 1. Monodispersed silver nanoparticle pseudo-standards provided by JRC 
Standard Diameter TEM 
 
[nm]* 
First Standard 
Deviation 
[nm]* 
Hydrodynamic  
Diameter(DLS) 
[nm] * 
Concentration by 
ICP-MS 
[µg mL
-1
]*** 
AgNP10 10(±4)** N/A N/A 17.7 
AgNP20 19.6 1.6 N/A 19.1 
AgNP30 32.3 3.2 44.8 13.2 
AgNP40 40.6 3.0 53.7 18.3 
AgNP50 52.4 5.9 58.1 19.8 
AgNP60 57.4 4.0 66.7 19.4 
AgNP70 68.5 4.2 69.0 21.1 
AgNP80 77.1 6.4 83.0 20.0 
AgNP90 88.9 4.3 86.8 18.1 
AgNP100 99.4 7.0 97.7 18.7 
*  Manufacturer(1) specification unless otherwise indicated 
**  Manufacturer(2) specification (8.6nm by Centrifugal Liquid Sedimentation)  
***  JRC Laboratory (average concentrations on 3 replicate measurements) 
 
6 Description of apparatus required for SOP 
6.1 General apparatus 
The method foresees the participating laboratories have access to the following apparatus: 
 Suitable calibrated pipettes for sample dilution  
 Ultrasonic bath for homogenization of particle solution 
 pH meter for preparation of eluent solution 
 Asymmetric flow field flow fractionation separator: Consisting of a least one solvent pump, 
solvent reservoir(s), a separation channel and a data acquisition and handling computer 
system.  
 Inductively Coupled Plasma Mass Spectrometry (ICP-MS):  
As can be seen from Fig.1 the elution output from the AF4 separation channel (or UV detector if 
present) is normally coupled directly (on-line) to the ICP-MS via a three-way switching valve. This 
valve is optional but allows the column to be rapidly isolated from the ICP-MS during ICP-MS mass 
calibration with ionic standards (section 7.5) 
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After leaving the separation channel and before entering the ICP-MS, the eluent should be acidified 
via a T-connector, using nitric acid solution (it may contain an additional internal ‘dilution’ standard 
such as Re at a concentration of 20 µg L-1) and directed to the nebulizer of the ICP-MS for on-line 
detection and quantification of various AgNP size fractions. The mixing of the eluent with an acid 
solution is necessary to reduce possible loss of silver in the tubing before reaching  
the ICP-MS detector. The use of an internal reference for flow monitoring in the acidifier solution is 
optional but may be useful for monitoring dilution and AF4 outlet flow. On the contrary, an actual 
ISTD (i.e. Rh at a concentration of 50 µg L-1 in 1% nitric acid) to be used for Ag quantification, is 
continuously added on-line using the pump of the ICP-MS nebulizer.   
 
Fig.1  Schematic of preferred AF4-(UV)-ICP-MS online system 
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6.2 Specific information of apparatus used by JRC in method development  
The following section will provide specific information on the equipment used by JRC in method 
development. This data is provided for information only and participating laboratories are free to use 
AF4 conditions deemed most suitable to their own instrumentation and standard operating practices. 
6.2.1 AF4 equipment used by JRC in method development 
The apparatus used in method development by JRC was a Postnova Model AF2000 equipped as 
follows.  For alternative systems some of these parameters might change and require adaptation. 
i. Channel: The channel used for the development of the current method was a Postnova 
patented channel with a channel length of 280mm and channel area=3160mm2 
ii. Channel Spacer: The channel spacer used for the development of the current method 
was 350 µm thick. 
iii. Channel Membrane: The membrane material used for the development of the current 
method was regenerated cellulose (for aqueous applications) with a 10 kDa cut-off. 
iv. Injection Loop Volume: The injection loop volume used for the development of the 
current method was 50 µL 
v. UV/Vis detector: SPD-20AV from Postnova 
6.2.2 ICP-MS equipment used by JRC in method development 
JRC method development done using an Agilent 7700x ICP-MS system and the following conditions 
were set: 
Table 2  Parameters used for ICP-MS instrument at JRC 
 
Parameter Details 
RF-Power 1550 w 
Reflected- Power 12.2 V 
Temperature ca. 6500-8000 K 
Nebuliser type 
Nebuliser flow rate  
MicroMist (quartz) 
0.8 L min-1  
Spray Chamber Scott (quartz) 
Scan mode and Resolution Time Resolved Analysis (TRA) 
Integration Time 3.0 sec 
Sampling Time 45 mins 
Monitored masses Ag(107, 109)  
Re(185, 187)  
Rh(103) 
 
 
Connection between AF4 and ICP-MS in between runs was removed to allow a purge of the AF4 and 
a simultaneous cleaning of the ICP-MS with 2-5% nitric acid through the syringe pump. Background 
counts of Ag 107 were monitored till an acceptable and stable level was reached. Once AF4 and ICP-
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MS were reconnected (with AF4 in pre-run conditions), 107, 103 and 187 counts were monitored 
and noted. New measurements were not started before acceptable ICP-MS conditions were reached 
(stable 187 and 103 counts and relatively low 107 background).  
6.2.3 Use of UV-VIS Detector 
Figure 1 shows a system equipped with a UV/VIS detector which is used as auxiliary detector for the 
preparatory steps of method optimization and later confirmation purposes with ICP-MS detection. 
For the detection of silver nanoparticles across the size range 10-100 nm it is recommended that the 
UV/VIS detector monitoring wavelength is set at 420 nm which has been found to be a suitable 
compromise value which allows detection of all particles in the expected size-range. 
 
7 Standard Operating Procedure(SOP) 
7.1 Sample preparation and sample storage 
Before using samples they must be brought to room temperature and homogenized for 1 minute 
with a vortex mixer prior to injection. If available it is additionally recommended to subject samples 
to a short 10s bath sonication.  
All samples must be stored at 4°C away from extended exposure to light and air. Stock solutions of 
the pseudo-standard have been prepared under nitrogen and it is recommended that after opening, 
the head-space of the vial refilled with nitrogen before reclosing and returning to 4°C storage. Vials 
of undeclared mixtures should be opened only on the day of analysis. 
7.2 Preparation of mixtures 
Silver nanoparticle monodispersed standards of known size and concentration provided by JRC 
(Table 1) are mixed together by trial participants to obtain bimodal/trimodal mixtures.  
7.2.1 AgNP10, AgNP40 and AgNP100 mixture [approx. 800 ngmL-1 each] 
After thorough homogenization of standard solutions (sonication and vortexing), transfer exactly 40 
µL of the 10 nm, the 40 nm and the 100 nm silver standard solutions into a vial and add exactly 880 
µL of ultrapure water Mix (sonication and vortexing) thoroughly prior to injection. 
7.2.2 AgNP20 and AgNP60 mixture [approx. 800 ng mL-1 each] 
After through homogenization of standard solutions (sonication and vortexing), transfer exactly 40 
µL of the 20nm and 40 µL of the 60nm silver standard solutions into a vial and add exactly 920 µL of 
ultrapure water. Mix (sonication and vortexing) thoroughly prior to injection. 
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7.2.3 AgNP40 and AgNP60 mixture [approx. 800 ng mL-1 each] 
After through homogenization of standard solutions (sonication and vortexing) transfer exactly 40 µL 
of the 40 nm and 40 µL of the 60 nm silver standard solutions into a vial and add exactly 920 µL of 
ultrapure water. Mix (sonication and vortexing) thoroughly prior to injection. 
 
7.3 Optimisation of elution parameters for particle recovery and separation 
In this section the trial participants will be given the opportunity to familiarize themselves with some 
of the main separation parameters. If not already coupled to an ICP-MS, this part can be successfully 
completed using only a UV/VIS detector (wavelength set at 420 nm).  
7.3.1 Optimisation of void peak size 
One of the reasons for analyte loss in AF4 is a very pronounced void peak which in part may contain 
small particles which elute in an uncontrolled manner. The void peak size depends primarily on the 
injection/focusing time in relation to the injected volume and the initial cross-flow. 
A too short injection/focusing time and/or a too low initial cross-flow, both lead to enlargement of 
the void peak. These conditions may be optimised in the following manner.  
A series of injections for the optimization of the void peak size are done starting from a “standard” 
separation method/profile (see box below) using the mixture (AgNP10, AgNP 40 and AgNP 100) 
described in section 7.2.1 
For users of PostNova systems the method/profile settings in the following box may be appropriate. 
For alternative equipment the choice of starting conditions must be determined from operator 
experience or from manufacturer recommended values. 
Standard Separation Method Parameters for Postnova AF4: (see annex 2) 
Focus Step 
 Injection Flow  : 0.2 mL min-1 
 Injection time  : 5 mins 
 Cross-Flow  : 1 mL min-1 
Elution Step 
Starting cross flow of 1 mL/min with linear decrease to 0.1mL min-1 during 40 min followed by a 
further constant cross flow of 0.1 mL min-1 for 10 min 
Detector flow rate   : 0.5 mL min-1 
Injection sample loop volume : 50 µL  
The following proceed may be followed to optimize the conditions for acceptable void peak 
separation:  
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a) Using the tri-modal mixture (7.2.1) a series of elutions with different starting cross-flow 
values (increasing values in the range 0.5-2 mL min-1)  should be run to determine the 
minimum cross-flow conditions which permit full separation of the void peak and AgNP10 
peak in the fractogram.  In each of these elutions the values of injection flow and focus times 
must be kept constant. Suitable starting values for injection flow and time should be based 
on operator experience or instrument manufacturer recommendation for method 
development. To obtain a quantified measure of the void peak separation from the AgNP10 
the capacity factor described in section 7.3.1.1 should be calculated. When separation 
conditions are found in which the capacity factor is >0.6 these values may be adopted for 
use in the next step of the optimisation.   
b) Once the void peak can be fully separated from the AgNP10 peak various focusing times 
(injection times) shall be tried and the resulting void peak areas (sizes) compared with each 
other by overlaying the runs. An excessively short focusing time will produce a higher ratio 
of the void peak to the AgNP10 peak while excessively long focusing times may lead to 
distortion or loss of intensity of one or more of the AgNP10, AgNP 40 and AgNP 100 peaks. A 
compromise value of focusing time should be selected between these two extremes. The 
fractogram shown in Figure 2 illustrates an elution profile obtained with acceptable 
combination of cross-flow, focusing and injection times.   
Results shall be recorded by providing overlaid fractograms of all runs and by filling the relevant 
table in Annex 3. Where possible, the data from the fractogram (Elution time and UV and ICP-MS 
isotopic signal as counts/second) should be made available in electronic format by inclusion in the 
appropriate excel template which will be supplied. 
7.3.1.1 Determination of capacity factor (retention factor) k’ for AgNP10 
Solution to inject: The AgNP10, AgNP40 and AgNP100 mixture (prepared under 7.2.1) is injected. 
The separation quality between the void and the AgNP10 peak is calculated from the fractogram by 
applying the following equation (see also example Fig 2).                
k’(AgNP10) = (tR(AgNP10) – tV(void peak)) / tV (void peak) 
 
where k’(AgNP10) is the capacity factor for AgNP10, tR(AgNP10) is the retention time of the AgNP10 
peak and tV(void peak) is the retention time of the void peak. 
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The capacity factor should be >0.6 (for fractograms both recorded with UV/VIS and ICP-MS 
detectors). In case it is smaller than 0.6, the AgNP10 fraction is eluted too quickly and will not be 
well separated from the void peak. 
7.3.2 Optimization of peak separation parameters 
Once suitable injection/focusing conditions have been determined as described in section 7.3.1 it is 
necessary to determine an elution step (eg. linear decrease from 1ml min-1 to 0.1ml min-1 in 40min) 
which allows an acceptable resolution between particles of different sizes.  To assess the degree of 
separation achievable with any given elution step it will be necessary to calculate values of peak 
resolution using the method described in the following section 7.3.2.1. 
7.3.2.1 Determining resolution between peaks  
A measure of how well species have been separated is provided by measurement of the resolution. 
The resolution of two species, A and B, is defined as 
 
Where W is the peak width at the peak base and tR is the retention time of peaks A and B. 
Baseline resolution is achieved when R = 1.5 
Fig 2. Fractogram example of an AgNP10/40/100 mixture (coupled to UV/VIS detector) 
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7.3.2.2 Optimisation of peak separation using tri-modal mixture (AgNP10/40/100) 
This should be done by firstly analysing the trimodal mixture (AgNP10/40/100) and using the 
resulting fractogram to calculate the resolution between the  AgNP10/40 and AgNP40/100 peaks as 
described previously. If the resolution achieved does not satisfy the minimum requisites quoted 
alternative elution conditions should be tested until the minimum required peak separation is 
achieved. The target should be to achieve a resolution as follows   
a) for UV/VIS detector this should be at least R=1.5 for the fractions AgNP10/40 and R>1 for the 
fractions AgNP40/100. 
b) for ICP-MS as detector this should be around 1 for both AgNP10/40 and AgNP 40/100 fractions. 
Coupling the AF4 to an ICP- MS leads to peak-broadening resulting in less optimized peak 
separations. 
Results shall be recorded by providing the fractogram(s) and the calculated resolutions and 
recording them in Annex 3. Where possible, the data from the fractogram (Elution time and UV and 
ICP-MS isotopic signal as counts/second) should be made available in electronic format by inclusion 
in the appropriate excel template which will be supplied. 
7.3.2.3 Optimisation of peak separation using (AgNP20 and AgNP60) mixture 
Once the trimodal mixture can be satisfactorily separated the resulting optimised focusing/elution 
conditions should be used to measure the resolution using the biomodal mixtures AgNP20/60 
prepared in sections 7.2.2. If the resolution achieved does not satisfy the minimum required values 
quoted below alternative elution conditions should be verified until the required peak separation is 
achieved.  
The target should be to achieve a resolution of at least R=1.0 for the fractions AgNP20/60 (for both 
UV/VIS and ICP-MS detection) 
Results shall be recorded by providing the fractogram(s) and the calculated resolutions and 
recording them in Annex 3 
Where possible, the data from the fractogram (Elution time and UV and ICP-MS isotopic signal as 
counts/second) should be made available in electronic format by inclusion in the appropriate excel 
template which will be supplied. 
7.3.2.4 Optimisation of peak separation using (AgNP40 and AgNP60) mixture  
The final verification of the elution profile should be done using a sample of the AgNP40/60 mixture. 
The final step in optimisation requires that the elution of the AgNP40/60 mixture should show at 
least a separation of peak maxima as can be seen in Figure 3. With the optimised separation 
conditions it is probable that the AgNP40 and AgNP60 will not be base line separated. The aim is to 
achieve at least a separation of the peak maxima as shown in Figure 3.  
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Fig 3. Separation of AgNP40 and AgNP60 fractions (coupled to UV/VIS detector) 
If this level of separation is not observed then minor adjustments to the elution profile should be 
made until this is achieved.  
Results shall be recorded by providing the fractogram(s) and where possible, the data from the 
fractogram (Elution time and UV and ICP-MS isotopic signal as counts/second) should be made 
available in electronic format by inclusion in the appropriate excel template which will be supplied.  
7.4 Particle size determination   
Retention times will be used as a means to determine particle size following a calibration curve 
obtained by injecting monomodal pseudo standards into the AF4 as follows. 
7.4.1 Particle size calibration 
The size of nanoparticles in the provided samples is determined by calibrating the AF4 for size 
against elution time using the supplied mono-dispersed silver standards (supplied by JRC). 
All single mono-dispersed standards shall be diluted transferring 30 µL of the concentrated 
(provided) standard solution into a vial and adding subsequently 960 µL of ultrapure water resulting 
in approximate concentrations of 600 ng mL-1. For exact concentrations please calculate using 
concentrations listed in Table 1. 
These diluted fractions are injected singularly (or in peak-maxima separated mixtures) and the 
resulting retention times plotted against the particle diameter (see example Figure 4). 
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Fig 4. Example of dependency of particle size on retention time 
 
An interpolated data points fitting curve (trendline, see example in Figure 4) can be easily extracted 
with most spreadsheet software packages (e.g. MS Excel, Origin).  
Results of the size-retention time calibration shall be recorded in the excel template supplied. 
7.5 Quantification of silver in identified particle size fractions 
Silver concentration of size fractions (peaks) in sample mixture may be determined as usually done 
in participants’ laboratory. In alternative to this may be done by calibration post-channel with ionic 
silver solutions (not provided by JRC) as described below in section 7.5.1. In either case it is 
requested that participants include a description of the method used in reporting Annex 4  
7.5.1 Post-column calibration with ionic silver solution 
All the following steps have to be performed daily, once ICP-MS conditions have been monitored, 
tuning performed and usual quality requirements fulfilled. Once the ICP-MS is running in 
chromatographic (or time resolved) mode according to section 6, the post column calibration 
approach can be used.  
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Fig 5. Possible set-up for ionic post-column calibration (AF4 Column excluded)   
In this approach, the AF4 outlet is disconnected from the ICP-MS detector using the three switching 
valve and a peristaltic or syringe pump is used instead, simulating the flow of the AF4 while reducing 
the silver background signal from the column (see fig. 5). The flow of this pump must be set at the 
same flow rate as the AF4 outlet (0.5ml/min) and it has to pump freshly prepared AF4 eluent set at 
pH 9.2. The ionic standards have to be diluted in freshly prepared AF4 eluent set at pH 9.2 at exact 
concentration using a range that is suitable for expected level of silver in the fractions eluting from 
the AF4. With the JRC instrument a 5 point calibration of 0, 1, 12.5, 25, 50 ng mL-1 in AF4 eluent was 
normally done. 
The ICP-MS is calibrated post-channel by injecting ionic silver calibration solutions through a sample 
introduction valve equipped with a 1 mL loop.  During the entire process both dilution and internal 
standards have to be in place simulating the set-up in place during a normal AF4-ICP-MS run. Signals 
to be monitored are 107, 109, 103, 185 and 187 as described before.  
For quantification, silver signal (107) has to be divided by ISTD signal (i.e. 103 for Rh) for both 
samples and calibrants. Ratio 107/103 has to be plotted versus retention time on the ICP-MS 
detector (in minutes). Peak area can be integrated by using available software or statistic 
environments.  Finally areas have to be used versus concentrations to create calibration curves. A 
simple linear regression function can be used, without forcing it through the origin. Ionic calibration 
has to be run at least once a day and every time the plasma is switched on/off and tuned.  
 
 
 
 
 
Nebuliser of 
ICP-MS 
 
Injection valve for 
ionic standard (1ml 
loop) 
 
Three way 
switch 
valve 
Peristaltic 
pumps 
Syringe or 
peristaltic 
pump 
 
AF4 
eluent  
pH 9.2 
 
AF4 
eluent 
pH 9.2 
 
Internal Standard 
for ICP-MS (ISTD) 
Optional internal reference 
for flow monitoring 
98 
7.6 Evaluation of ICP-MS detector response to particle size 
In this test it is requested that the previously used tri-modal mixture of nanoparticles be analysed at 
three different total concentrations. This section serves to verify whether the ICP-MS response to 
the eluted Ag nanoparticles can be assumed to be independent of particle size.   
7.6.1 Sample Preparation  
1) Sample preparation (Tri-modal mix 800ng mL-1):  A fresh stock solution of AgNP10, 
AgNP40 and AgNP100 mixture should be prepared as previously detailed in section 7.2.1: [approx. 
800ng mL-1 of each size) 
2) 50% tri-modal sample (Tri-modal mix 400ng mL-1):  500ul of the above tri-modal mix 
should be diluted in 500ul of ultrapure water to give a solution containing approx. 400ng mL-1 of 
each size) 
3) 10% tri-modal sample (Tri-modal mix 80ng mL-1):  100ul of the stock solution (Tri-
modal mix 800ng mL-1) should be diluted in 900ul of ultrapure water to give a solution approx. 
80ng mL-1 of each size. 
7.6.2 Mass calibration of ICP-MS 
The ICP-MS system should be calibrated as normally done in the participant’s laboratory or 
alternatively using the ionic standards as described in section 7.5. 
7.6.3 Analysis of tri-modal mixtures 
Using the optimized elution profile previously developed the three samples of the tri-modal stock 
solution, (80ng mL-1, 400ng mL-1 and 800ng mL-1), should be analysed in order of increasing 
concentration.  
Results shall be recorded in Annex 4 by providing the fractogram graphs and the calculated 
concentrations for each of the three particle sizes. Where possible, the data from the fractogram 
(Elution time and UV and ICP-MS isotopic signal as counts/second) should be made available in 
electronic format by inclusion in the appropriate excel template which will be supplied. 
7.7 Determination of particle fraction sizes and concentrations in unknown samples 
To assess the effectiveness of the methodology in an impartial manner, participants will be required 
to analyse a series of two samples each of which contains at a mixture of at least two size(s) of 
silver nanoparticle (size range 10-100 nm) in a concentration range between 100-1000ng 
mL-1.  The samples will be labelled UNKNOWN SAMPLE A, and UNKNOWN SAMPLE B and no 
information will be provide about particle sizes or concentrations  
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7.7.1 Analysis of unknown sample A  
The unknown sample A should be diluted before use.  After thorough homogenization of the 
solution (sonication and vortexing), transfer exactly 50 µL of the mix into a vial and add exactly 950 
µL of ultrapure water.  Mix (sonication and vortexing) thoroughly prior to injection. 
 
The diameters of the silver nanoparticles contained in the sample are calculated from the curve of 
elution time-particle size determined in 7.4. 
The concentration of the eluted silver fractions is determined as described under 7.5 
Results are recorded in Annex 5. Where possible, the data from the fractogram (Elution time and UV 
and ICP-MS isotopic signal as counts/second) should be made available in electronic format by 
inclusion in the appropriate excel template which will be supplied. 
7.7.2 Analysis of unknown sample B 
The unknown sample B should be analysed as received (no dilution necessary). The homogenized 
(bath sonicated and vortexed) sample should be injected into the AF4-ICP-MS system and eluted 
according to the optimise procedure determined previously in section 7.3 
The diameters of the silver nanoparticles contained in the sample are calculated from the data fitting 
curve as determined in 7.4. 
The concentration of the eluted silver fractions is determined as described under 7.6 
Results are recorded in Annex 5. Where possible, the data from the fractogram (Elution time and UV 
and ICP-MS isotopic signal as counts/second) should be made available in electronic format by 
inclusion in the appropriate excel template which will be supplied. 
8 Reporting of results 
All results shall be reported in the tables found in annexes 3, 4 and 5.  Relevant fractograms and 
calibration curves shall be provided as supporting materials in Word or PDF format. Where possible 
the data from the fractograms (Elution time, UV and ICP-MS ion signals) should be made available in 
an electronic format in the excel files which will be supplied. 
Please return annexes by e-mail to Douglas Gilliland at the following address: 
Email: douglas.gilliland@jrc.ec.europa.eu 
Contact details 
Dr. Douglas Gilliland 
Joint Research Centre of the European Commission 
Institute for Health and Consumer Protection (IHCP) 
TP 203 
100 
Via E.Fermi 2749 
21027-Ispra (VA) 
ITALY 
Tel. +39 0332 785603 
 
 
 
Annex 1: List of materials provided by JRC 
 
The parcel send out by JRC contains the following items: 
 Vial with AgNP10 stock-solution 
 Vial with AgNP20 stock-solution  
 Vial with AgNP30 stock-solution  
 Vial with AgNP40 stock-solution  
 Vial with AgNP50 stock-solution  
 Vial with AgNP60 stock-solution  
 Vial with AgNP70 stock-solution  
 Vial with AgNP80 stock-solution  
 Vial with AgNP90 stock-solution  
 Vial with AgNP100 stock-solution  
 Vial with unknown Sample A (requires dilution) 
 Vial with unknown Sample B(to be used as supplied) 
 Materials Safety Data Sheet 
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Annex 2: Parameters for AF4 elution method developed on Postnova AF2000 
 
 
 
Annex 3: Result Sheet: Optimisation of Separation Parameters (Section 7.3) 
A.3.1 General Information 
Name of Company/ 
Research Institution 
 
 
 
Address  
 
 
 
Contact Person  
 
Email Contact Person  
 
Phone Contact Person  
 
Period when analysis were done 
(date) 
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A.3.2 Instrumental Information 
A4 Specifications 
(Manufacturer, Model) 
 
 
AF4 Loop Volume [µL] 
 
 
Separation Channel Specifications 
(Size) 
 
 
Membrane used 
(Type, Part#, Lot#) 
 
 
ICP-MS specifications 
(Manufacturer, Model, spray 
chamber, nebulizer, cones, nebulizer 
pump flow) 
 
 
 
 
 
A.3.3 Optimisation of void peak size [see section 7.3.1] 
A.3.3.1 Optimisation of void peak size – Results during development 
Attempts Injection Loop 
Volume [mL] 
Initial Cross-Flow 
[mL/min] 
Injection Flow 
[mL/min] 
Injection 
time 
[min] 
Void Peak 
Area [AU] 
1 
 
     
2 
 
     
3 
 
     
4 
 
     
5 
 
     
 
A3.3.2 Final optimised parameters 
Parameters Values 
 
Injection Flow [mL/min] 
 
 
Injection Time [min] 
 
 
Initial Cross-Flow [mL/min] 
 
 
 
Please annex all relevant fractograms 
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A3.3.3 Capacity factor under optimised conditions [section 7.3.1) 
Date of Analysis: .                                             . 
 
Capacity factor k’ for AgNP10  
k’(AgNP10)  
 
Please provide fractograms as supporting material. 
 
A.3.4 Optimisation of peak separation– results under optimised conditions (section 7.3.2) 
A.3.4.1 Resolution calculation for AgNP10/40 and AgNP40/100 (section 7.3.2.1)  
R(AgNP 10/40)  
 
R(AgNP 40/100)  
 
Please provide fractograms as supporting material. 
 
A.3.4.2  Resolution calculation for AgNP20/60 (section 7.3.2.2)  
R(AgNP 20/60)  
 
Please provide fractograms as supporting material. 
 
A.3.4.3 Verification of peak separation using (AgNP40 and AgNP60) mixture (section 7.3.2.3) 
 
 
 
 
 
FRACTOGRAM OF (AgNP40/AgNP60) MIXTURE (Section 7.3.2.3) 
 
 
 
 
 
 
 
 
Please provide fractograms as supporting material. 
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Annex 4: Result of known Tri-modal sample mixtures (approx. 80, 400 and 800 ng mL-1 ) 
A.4.1  Trimodal mixture approx. 80 ng mL-1   Date of Analysis:  .                                             . 
Detected size fractions [nm 
(e.g. 10nm, 40nm, 80nm) 
Ag mass in each peak fraction  
Fraction  Particle Size 
[Diameter, nm] 
Measured mass of Ag Expected mass of Ag(1) 
1 
 
10nm   
2 
 
40nm   
3 
 
100nm   
Please provide fractograms as supporting material. 
A.4.2  Trimodal mixture approx. 400 ng mL-1   Date of Analysis:  .                                             . 
Detected size fractions [nm 
(e.g. 10nm, 40nm, 80nm) 
Ag mass in each peak fraction  
Fraction  Particle Size 
[Diameter, nm] 
Measured mass of Ag Expected mass of Ag(1) 
1 
 
10nm   
2 
 
40nm   
3 
 
100nm   
Please provide fractograms as supporting material. 
A.4.3  Trimodal mixture approx. 800 ng mL-1 Date of Analysis:  .                                             . 
Detected size fractions [nm 
(e.g. 10nm, 40nm, 80nm) 
Ag mass in each peak fraction  
Fraction  Particle Size 
[Diameter, nm] 
Measured mass of Ag Expected mass of Ag(1) 
1 
 
10nm   
2 
 
40nm   
3 
 
100nm   
Please provide fractograms as supporting material. 
(1) Values of expected concentrations should be calculated from actual dilutions done (if different 
from those in the section 7.6.1) and assuming the Ag concentrations for each mono-modal stock 
solution as detailed in Table 1  
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A4.4.4 Description of procedure used to calibrate ICP-MS response to silver 
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Annex 5: Result of unknown samples (A) and (B) 
A.5.1 Sample ID: UNKNOWN SAMPLE A  Date of Analysis:  .                                             . 
Detected size fractions [nm] 
(e.g. 10nm, 40nm, 80nm) 
 
Fraction  Particle Size 
[Diameter, nm] 
Concentration 
[ng mL
-1
] 
1* 
 
  
2 
 
  
3 
 
  
4 
 
  
* numbering is arbitrary and does not mean that this sample contains 4 different particle size 
fractions 
Please provide fractograms as supporting material. 
Fractogram of Unknown mixture A (diluted)  
 
 
 
 
 
FRACTOGRAM OF UNKNOWN MIXTURE A (DILUTED) (Section 7.7.1) 
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A.5.2 Sample ID: UNKNOWN SAMPLE B  Date of Analysis:  .                                             . 
Detected size fractions [nm] 
(e.g. 10nm, 40nm, 80nm) 
 
Fraction  Particle Size 
[Diameter, nm] 
Concentration 
[ng mL
-1
] 
1* 
 
  
2 
 
  
3 
 
  
4 
 
  
* numbering is arbitrary and does not mean that this sample contains 4 different particle size 
fractions 
Please provide fractograms as supporting material. 
 
Fractogram of unknown sample B (as supplied)  
 
 
 
 
 
FRACTOGRAM OF UNKNOWN MIXTURE A (as supplied) (Section 7.7.2) 
 
 
 
 
 
 
 
 
  
GETTING IN TOUCH WITH THE EU 
In person 
All over the European Union there are hundreds of Europe Direct information centres. You can find the address of the centre 
nearest you at: http://europea.eu/contact 
On the phone or by email 
Europe Direct is a service that answers your questions about the European Union. You can contact this service: 
- by freephone: 00 800 6 7 8 9 10 11 (certain operators may charge for these calls), 
- at the following standard number: +32 22999696, or 
- by electronic mail via: http://europa.eu/contact 
FINDING INFORMATION ABOUT THE EU 
Online 
Information about the European Union in all the official languages of the EU is available on the Europa website at: http://europa.eu 
EU publications 
You can download or order free and priced EU publications from EU Bookshop at: http://bookshop.europa.eu. Multiple copies of 
free publications may be obtained by contacting Europe Direct or your local information centre (see http://europa.eu/contact). 
  
K
J-N
A
-2
8
6
8
2
-EN
-N
 
doi:10.2760/737551 
ISBN 978-92-79-70520-5 
